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Two Methodologies in Pursuit of the Elucidation of Copper (II)—Centered 
Bioinorganic Chemistry 
 
William John Wagner 
 
ABSTRACT 
 
Copper is a widely distributed transition metal in the earth’s crust and 
has been adopted in a variety of biological systems. In many ways the 
biochemical usefulness of copper stems from its positive redox potential. This 
positive redox potential allows copper to assist in the movement of electrons. 
Copper ions can be found in natural systems as either CuI, CuII, or CuIII in 
part due to this redox potential. While CuII -centered biochemistry has been 
studied for years, mechanistic details in certain CuII -centered redox 
reactions remain unresolved. This thesis presents two methodologies for 
studying natural systems with known CuII -centered redox capabilities in 
order to better elucidate the mechanistic intricacies of copper ion chemistry. 
The first method explored involves the promiscuous enzyme Streptomyces 
griseus aminopeptidase (SgAP) which although known primarily as a 
peptidase has been shown to oxidize catechol under near physiological 
conditions in vitro when its native ZnII ions are replaced by CuII ions. Protein 
x 
 
engineering techniques were utilized toward expression a functional 
recombinant enzyme in wild type and mutant forms. The goal was to utilize 
site directed mutagenesis of residues in the active site to determine which 
residues are involved in both the hydrolysis and/or the oxidative activities of 
SgAP. The second methodology explored was the use of the N-terminus of 
Histatin-5, a naturally occurring peptide that is known to form complexes 
with CuII, as a model system to study CuII -centered oxidation chemistry. 
Metal-Peptide complexes are much more simplified systems which use the 
same building blocks as proteins, but reduce the structure to the minimal 
functional unit necessary for activity.  This in turn, simplifies the study of 
their catalytic chemistry as influences outside of the active region are greatly 
reduced. Furthermore, chemical synthesis of short peptides is easily 
performed and inexpensive in comparison to protein engineering, thus 
enabling further exploration, if deemed necessary, to be a feasible and 
economically viable possibility. 
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Chapter I:   INTRODUCTION TO STREPTOMYCES GRISEUS  
AMINOPEPTIDASE 
1.1   Hydrolysis 
Hydrolysis is a type of chemical reaction that breaks a bond by adding 
water through the activation of water to generate a powerful hydroxide 
nucleophile.  This reaction is the primary mechanism for catabolism in cells 
and is able to break down all classes of macromolecules in the cell.  Although 
hydrolysis can occur spontaneously, it is not particularly favorable, resulting 
in macromolecules being rather stable at physiological pH.  Thus, the 
degradation of macromolecules requires enzymatic catalysis to proceed at a 
rate suitable for the metabolic functions of the cell.  Generally, the 
breakdown of macromolecules is highly specific, with different classes of 
enzymes carrying out the degradation of different classes of macromolecules.  
The three-dimensional structure of the macromolecules and the geometry of 
the bonds that hold them together determine the structure and amino acid 
composition of the catalytic site of the enzyme responsible for degrading 
each macromolecule.  Although variations occur within each class of enzyme, 
the structural constraints placed upon these enzymes by their substrates lead 
to similarities within each class.  Herein, the hydrolysis of two types of 
macromolecules, peptides and ester-linked molecules, is discussed, which is 
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followed by a description of an enzyme that, although known primarily as a 
peptidase, also has the ability to hydrolyze ester linkages.  
1.2 Hydrolysis of Esters 
Esters are an important target for hydrolysis in biological systems.  
Ester bonds can be found in energy storage uses (i.e. ester linkages of 
triglycerides in fats).  Their presence in carbohydrates means they also 
contribute to structural integrity of plant cell walls1 and also the exoskeleton 
of insects.2  Esters are also found as the backbone of nucleic acids in the 
form of phosphodiesters as well as the short term energy carrier ATP.  While 
the reaction mechanisms of peptide and ester hydrolysis are similar, there 
are key differences in phosphoester hydrolysis.  In traditional esters the 
nucleophilic water attacks from the top or bottom of the carbonyl plane.  In 
phosphoester hydrolysis, the hydroxide attacks in an “in-line” SN2-like 
manner attacking the carbonyl carbon from the side directly opposite the 
leaving group.  This SN2-like attack leads to a tetrahedral transition state in 
carbonyl esters (RCOOR’) but a trigonal bipyramidal transition state in 
phosphoesters.   
1.3 Hydrolysis of Peptides 
   Peptide bond cleavage in biological systems is a function performed 
by enzymes called peptidases.  Peptidases come in three general classes: 
metal-dependent, serine, and cysteine proteases.  The significant role of 
peptide bond hydrolysis in biology cannot be overstated due to its 
involvement in digestion of peptides, regulation of hormones, and the  
  
Figure 1-1:  Mechanism of Ester Hydrolysis 
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maturation process of some proteins.3–5  In the absence of enzymatic 
assistance, the amide bond is particularly stable to all but the most extreme 
pH and temperature conditions.6  The mechanism for the hydrolysis of 
peptide bonds at alkaline pH is well established.  The hydroxide nucleophile 
attacks the carbonyl carbon from the top (or the bottom) of the plane of the 
peptide bond to form a tetrahedral transition state typical of peptide 
hydrolysis.7  This transition state is followed by the breaking of the peptide 
bond into an amine and a carboxylate ion.  Acid-catalyzed hydrolysis of the 
amide bond is slightly more complicated.8  The reaction begins with the 
protonation of the carbonyl oxygen followed by the attack of a water 
molecules to form the tetrahedral transition state.  The nitrogen is then 
protonated by another hydronium ion.  The acid is reformed when one 
oxygen atom is stripped of its proton to initiate lose of the transition state 
that ends with the amine being kicked off the carbon, resulting in a 
carboxylic acid and an amine.  
 In addition to the three major types of peptidases, there are various 
minor ones as well (namely Threonine, Aspartic acid and glutamic acid).  The 
classifications for peptidases are based on what is most responsible for its 
catalytic activity.  For instance, serine peptidases use the deprotonated side 
chain of a serine residue to act as the nucleophile for amide bond cleavage 
(as opposed to the hydroxide anion discussed in the preceding section).  
There are at least two essential parts to any peptidase.  First, it must have 
the substrate binding/recognition site.  Secondly, it must have a catalytic 
site.  Furthermore, peptidase may be classified as either exo- or  
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2: The mechanism of peptide hydrolysis. 
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endopeptidases, depending on whether the enzyme cleaves the protein in the 
middle (endo) or at the end (exo) of the polypeptide.   
1.4 Serine Peptidases 
 One of the most well studied serine peptidases is trypsin.  Trypsin is 
one of the many enzymes used in the digestive system of animals to 
breakdown peptide bonds.  Furthermore, it gained widespread use in the 
biological fields in the determination of amino acid sequences in proteins (i.e. 
the Sanger Method) due to its specificity for Lys and Arg residues.  The 
general mechanism for serine proteases starts with a His in the active site 
acting as a general base to form an hydrogen bond with the serine.  This 
activates the serine to attack the amide bond in a similar fashion described 
for peptide hydrolysis under basic conditions.  The protonation of the 
nitrogen in the transition state is carried out by the same His, which now is 
acting as a general acid.  After the hydrolysis of the peptide bond, the amine 
is free to disassociate, but the carboxylic acid terminus of the amino terminal 
fragment of the substrate is covalently bound to Ser-195.  Water is then 
activated by His to form hydroxide anion, which attacks the covalent 
intermediate, leading to another tetrahedral transition state.  This results in 
the release of the amino terminal fragment and the regeneration of the 
active site of the enzyme for another catalysis.9 
1.5 Cysteine Peptidases 
 Cysteine peptidases function in a very similar way to serine 
peptidases.  The main exception is that cysteine rather than serine acts as  
 Figure 1-3: Catalytic mechanism of the serine peptidase Trypsin. 
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the initial nucleophile by attacking the carbonyl carbon.  Various other amino 
acids within the active site play supporting roles, depending on the particular 
enzyme.  For example, papain uses Asn-175 to activate His-159 (rather than 
Asp as in Trypsin) which can then donate a proton to the nitrogen of the 
peptide bond.  This, of course, is a necessary step in peptide bond hydrolysis.  
Papain also utilizes Gln-19 as well as the nitrogen of Cys-25 to stabilize the 
carbonyl of the target peptide.10 
1.6 Metallopeptidases 
 Metallopeptidases are the most diverse group of peptidases due to two 
important factors.  First, a variety of metal components can be present.  For 
instance, the peptidase may contain zinc, iron, or manganese in the active 
site.  Second, a varying number of metal components present can complicate 
the catalytic mechanism.  Generally speaking, the most common 
metallopeptidases have either one or two metals in their catalytic centers; 
however, trinuclear metal centers do exist.  Moreover, the metal components 
need not be homogenous, but heterogeneous metal centers do exist as well.   
1.7 Angiotensin Converting Enzyme (ACE): a mononuclear zinc containing 
peptidase 
ACE is one of the most interesting mononuclear zinc peptidases.  In 
mammals this enzyme is responsible for at least two extremely important 
functions: the conversion of angiotensin I to angiotensin II (a potent 
vasopressor) and the breakdown as well as inactivation of the important 
vasodilator bradykinin.11  The overall result of the action of this peptidase is  
 Figure 1-4: The catalytic mechanism of the cysteine peptidase 
Papain. 
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to raise blood pressure.  Due to the potent hypertensive effect of ACE, it 
has become the main target in anti-hypertension treatment.  The drug class 
known as ACE inhibitors has become the first line of treatment not only for 
hypertension but also congestive heart failure and diabetes related and non-
diabetes related nephropathy.  A noteworthy feature of ACE homologues is 
their ubiquitous nature.  Homologues of ACE can be found in organisms that 
lack both angiotensin and a cardiovascular system.12 
ACE was first discovered in equine plasma samples; however, it is now 
known to be membrane bound, with highest concentrations in the epithelial 
cells of highly perfused tissues such as the kidney and lungs.12   In 
mammals, there are two forms of ACE.  The somatic form, sACE, is 
ubiquitously distributed around several types of tissue and consists of two 
transmembrane, a large cytosolic, and an N- and C-terminal extracellular 
domains.  The extracellular domains are similar, but each contains a different 
active site configuration and different substrate preferences12.  The other 
form found in mammals is the germinal or testicular ACE (gACE or tACE).  
gACE is 701 amino acids long and is identical to the C-terminal of sACE aside 
from the first 36 amino acids.11   Whereas the function of sACE is well 
established, the function of gACE is still unknown.  However, knockout mice 
studies have shown that deletion of gACE gene leads to greatly decreased 
fertility.12   
Unfortunately, there have been insurmountable difficulties with 
purification and subsequent crystallization of sACE.  One of the main reasons 
11 
 
is that ACE is heavily glycosylated, which leads to microheterogeneity of the 
oligosaccharides on the surface, preventing the ordered packing necessary 
for crystallization.11  Despite these difficulties, gACE was finally crystallized 
as well as the Drosophilia  homologue, AnCE.   
The similarities both in sequence and crystal structure between the 
active sites of another peptidase, thermolysin, and ACE suggest a similarity 
in mechanism.11  The accepted mechanism for thermolysin was proposed by 
Brian Matthews in 1988.13  The key feature is the zinc binding motif (HEXXH) 
in which the two active site His residues coordinate to the zinc ion.  There is 
also a Glu and a water molecule which complete the tetrahedral ligand field 
for the zinc.12  According to Matthews,13 the zinc cation fulfills an important 
role in the catalysis of peptide hydrolysis.  First, it binds the carbonyl of the 
target amide bond; this attack on the carbonyl carbon makes the resulting 
product more energetically favorable by balancing the oxygen anion.  The 
zinc also helps to activate the coordinated water molecule to form hydroxide 
and initiates the attack.  The active site then donates the proton to the 
amine group of the peptide bond.13  This stabilizes the amine group and by 
giving it a positive charge encourages the electron cascade from the carbonyl 
oxygen. 
The crystalographic study by Gordon et al.14 revealed other interesting 
aspects of this ACE.  The study shows why ACE preferentially digests small 
unfolded peptides over larger folded proteins.  The crystal structure contains 
a deep cleft that extends 30 Å into the interior of the globular protein, which  
 Figure 1-5:  Comparison of the crystal structures of the active sites of 
thermolysin and tACE. 
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is guarded by several charged residues at the clefts opening.  This cleft 
restricts the types of substrates that can possibly come in contact with the 
active site.  The study also revealed significant structural homology between 
tACE, AnCE, and neurolysin despite their low sequence homology.11   
This interesting situation where there is significant structural homology 
without sequence homology reveals a phenomenon of biology.  Nature 
follows the rules set forth by physical laws.  In order to facilitate the breaking 
of the surprisingly strong peptide bond, an enzyme must have both the 
correct three-dimensional structure to interact with the peptide bond and the 
appropriate amino acid side chains in the active site positioned in such a way 
that they facilitate the movement of atoms and/or electrons required for 
catalysis.  As such, it frequently occurs that enzymes that perform similar 
tasks have similar three dimensional structures.  There are two possible 
theories as for how these enzymes come to resemble each other so 
strikingly.  First, proteins encoded by genes that all arose from the same 
ancestral gene, which have undergone only conservative mutations, will 
result in a structure that remains largely unchanged, even though the actual 
sequence can differ to varying degrees.  This is termed divergent evolution.  
Alternatively, the particular structure could have evolved multiple times from 
different gene lineages.  This convergent evolution postulates that earlier 
structures that did not resemble each other eventually evolved to form a 
three dimensional shape that bears a strong resemblance to each other.  The 
evolutionary history of genes that encode proteins with similar functions can 
easily be determined using bioinformatics tools for phylogenetic analysis.  
14 
 
The important thing, however, is that it is through these relationships a study 
about one enzyme in a class can be inferred to another enzyme within its 
class.  It is known that certain sequences, such as the HEXXH motif,13 occur 
often and perform similar functions in different enzymes, and through this a 
starting point for future research on new enzymes can be found.  This 
inference system is often used to propose mechanisms of enzymes that have 
yet to be thoroughly studied by comparing their structural homology (or 
sequence homology) to well-studied enzymes  
1.8 Aeromonas proteolytica aminopeptidase (AAP): a di-zinc 
aminopeptidase 
Di-zinc aminopeptidases similar to AAP have been implicated in many 
disease states.  Many drugs used in the treatment of cancer and HIV can be 
linked to their effect on dinuclear metallopeptidases15- 20.  The similarities 
among peptidases of this class enable the inference of mechanisms relevant 
to all members from studies on particular model proteins.  As such, studying 
a similar di-zinc aminopeptidase from Aeromonas proteolytica and how 
inhibitors interact with it can serve as a model and lead to the design of new 
drugs with greater efficacy. 
Sequence and structural studies of AAP have revealed that there is a 
small hydrophobic pocket which is just large enough to support the N-
terminal amino acid.  This explains why AAP is an aminopeptidase and not an 
endopeptidase.  Inhibitor studies support the preference for hydrophobic 
residues in that alcohols with longer carbon chains and more steric hindrance 
15 
 
decreased the Ki from 860 mM with methanol to 0.98 mM with 3-methyl-1-
butanol.21  As is usual for peptidases, the tetrahedral transition state analogs 
are known inhibitors of AAP.  These inhibitors mimic the transition state of 
peptide hydrolysis and so are thought to compete for the active site.  Metal 
chelating agents are also inhibitors of AAP by sequestering the metal ions 
necessary for catalysis21.   
Through the inhibition as well as structural studies, the mechanism for 
AAP has been elucidated.  The zinc ions are in similar coordination spheres, 
both having one His residue directly coordinated to the zinc ion, a bridging 
water, and a bridging Asp.  Zn1 is coordinated to a Glu, while Zn2 is 
coordinated to an Asp.  This gives a distorted tetrahedral coordination sphere 
to each Zn ion.21  Upon substrate binding to the hydrophobic pocket, the 
bridging Asp coordination is replaced (on Zn1) by the carbonyl oxygen of the 
amide bond.  Water is then deprotonated by Glu-151 to form hydroxide, 
which attacks the carbonyl carbon.  The Zn1-carbonyl oxygen interaction 
stabilizes the tetrahedral transition state that came about by the hydroxide 
attack on the carbonyl carbon.  The proton gained by the Glu from the 
activation of water to hydroxide is transferred to the nitrogen of the amide 
bond along with the breaking of the amide bond and the release of the 
second amino acid.  The carbon to oxygen double bond then reforms as the 
oxygen dissociates from Zn1 and is replaced by the original bridging Asp. 
Other interesting studies from AAP involved the manipulation of the 
metal centers.  By removing the metals from the enzyme and then  
 Figure 1-6:  The active site structure of Aeromonas proteolytica 
aminopeptidase. 
 
 
 
 
 
 
 
 
16 
 
 Figure 1-7: The mechanism of peptide hydrolysis of the di-zinc 
metallopeptidase Aeromonas proteolytica aminopeptidase.21 
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reconstituting with two equivalents of another transition metal (copper, 
cobalt, or nickel) the activity is altered (some greatly increased activity while 
others reduced it).22 Addition of one equivalent of a different transition metal 
to the apo-AAP followed by an equivalent of ZnII dramatically increases the 
activity as well as changes the binding affinity (KM).22 
Although not medically relevant in any direct manner, the fact that 
nature has evolved only a few ways to perform peptide hydrolysis with a di-
nuclear center provides ample reason to study AAP.  The study of AAP over 
the medicinally relevant enzymes is preferred due to the simplicity of 
purification from natural sources.  Furthermore, the growth of bacteria is 
generally easier, and purification from bacteria is simpler.  As such, using 
bacteria as expression systems is preferable over eukaryotic cells.  Further 
complicating matters, acquiring recombinant proteins using DNA from a 
eukaryotic source contains many more hurdles than using a prokaryotic 
source.  Controlling of the expression of eukaryotic genes is more complex 
than bacterial genes, since the eukaryotic DNA is more complicated than 
bacterial DNA with the presence of introns and exons, necessitating post-
transcriptional modification (a problem overcome by using reverse 
transcriptase and processed mRNA).  Another complication in trying to 
express a eukaryotic gene in bacteria, even after removing the exons, is the 
great differences in codon usage frequencies between species that diverged 
so long ago.  This results in some codons calling for tRNAs that are available 
in abundance in the original eukaryote that simply do not exist in bacteria.  
19 
 
Thus, the translation is interrupted, resulting in a truncated and useless 
protein.  
1.9 Streptomyces griseus aminopeptidase (SgAP) 
The aminopeptidase from the culture medium of Streptomyces griseus 
is a single peptide chain with 284 residues (from the protein data bank) and 
a molecular weight of approximately 30kDa.23  Native SgAP contains two ZnII 
ions and requires both for peptidase activity.24  There is also a calcium cation 
that enhances activity of native SgAP, but due to the great distance between 
the calcium binding site and the catalytic center (25 Å) the mechanism of this 
activation remains unknown.  The substrate preference for SgAP is for large 
hydrophobic amino terminus residues24 preferably leucine25 and is maximally 
active at pH 8.0.26  The ligand environment for the first ZnII, based on x-ray 
crystallography studies, is proposed to be His-85, Asp-160, and a bridging 
Asp-97 and bridging dibasic phosphate.  The ligand environment for the 
second Zn2+ is His-247 and Glu-132 as well as the bridging Asp and dibasic 
phosphate.27  More recently, however, NMR studies suggest that the bridging 
phosphate is a product of the crystallization medium and is not bound to the 
active site in solution.  Instead, a water molecule or a hydroxide is proposed 
to replace the phosphate in the active site.26  This active site is quite similar 
to that of other aminopeptidases such as Aeromonas AP which was described 
previously.  The incredibly similar active site structures between AAP and 
SgAP suggest a similar mechanism for peptide hydrolysis, however key 
differences have been discovered (most notably those revealed by metal 
20 
 
titration and inhibitor studies).  The Active site of AAP and SgAP are 
compared in Figure 1-1.  Metal titration studies to SgAP have demonstrated 
that the two metal sites are not identical and that binding happens 
sequentially.  This is particularly noticeable when CoII is used as the titrant in 
the absence of calcium at pH 6.  Furthermore, these studies have shown that 
SgAP requires both metals for activity, as detectable activity is shown only 
when greater than one equivalent of CoII has been added.    There is a sharp 
rise in activity between 1 and 2 equivalents with an activity plateau forming 
shortly after 2 equivalents have been added to solution.25   
Although cobalt is not the native metal for SgAP, it is used because of 
its sequential binding, in the absence of calcium.  It should be noted, 
however, that sequential binding takes place with zinc as well.  It is, 
however, not as well pronounced.25 
Given the similarities between AAP and SgAP it is difficult to see why 
one would want to study SgAP.  There is, however, something peculiar about 
SgAP that sets it apart from most aminopeptidases.  The unique aspect of 
SgAP is that it is able to take a transition state analogue inhibitor like bis-p-
nitrophenylphosphate (BNPP) and catalytically hydrolyze it.  BNPP has 
become the standard for colorimetric assays of phosphoesterase activity.28  
That SgAP is able to hydrolyze both peptide bonds ane phosphoesters is a 
property entitled catalytic promiscuity.  Thus SgAP falls into an exclusive 
class of enzymes that seem to defy the fundamental dogma of enzymology. 
 
 
Figure 1-8:  Comparison of di-zinc aminopeptidase metal centers.  
Side by side comparison of the active sites of AAP (Right) and SgAP (Left).  
Clearly the ligand environments are very comparable.  One difference that is 
noteworthy is the inclusion of phosphate in the picture of the SgAP active 
site.  However, this is not seen in solution phase, but rather an artifact of the 
crystallization medium used to determine the active site composition.  In 
solution, a bridging hydroxyl or water is proposed (as is seen in AAP).   
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1.10 Catalytic Promiscuity and its relationship to evolution 
Central to the dogma of enzymology is that enzymes have evolved to 
catalyze a particular reaction, generally showing a strong preference for an 
exceptionally small range of substrates.  This was termed specificity.  Over 
the years, researchers have stumbled across many examples where not only 
did an enzyme catalyze a different type of substrate in the same class of 
reaction (hydrolysis of peptide bonds and hydrolysis of ester bonds, for 
example) but although considerably more rare, can also catalyze different 
types of reactions (hydrolysis and oxidation).   
There are various classes of “catalytic promiscuity”.  The most 
common class is functional group analogues where the bonds broken differ 
but the mechanism is likely the same.  This is common, for example, in a 
peptidase that also hydrolyzes esters.29  Another class involves the change in 
mechanism.  A mutation in the enzyme that decreases reaction rate but does 
not eliminate function must follow a less efficient path and therefore a 
different mechanism.29  An example of this is observed in a protein-tyrosine 
phosphatase,30 in which the catalytically important Cys was converted to Asp.  
This mutant retains some activity, and since the catalytic functional group 
was changed, the observed activity must be resulted via a different 
mechanism.29  Another class involves a change in substrate specificity.  
Changing the substrate specificity leads to slight changes in the transition 
state and can be considered as a promiscuous function.29 
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Merely being catalytically promiscuous is not uncommon.  The rate at 
which SgAP hydrolyzes BNPP is exceptionally high: 4x 1010 greater than the 
auto-hydrolysis of BNPP31 and this is very unusual.  Whereas most 
promiscuous activities show a rate that is a fraction of the native activity, 
SgAP activity towards 1 mM BNPP is 33.7 nmol min—1 mg—1 versus SgAP’s 
activity to 1 mM Gly-pNA of 19.3 nmol min—1 mg—1.32  Furthermore, the 
activity of SgAP on BNPP surpasses that of several natural alkaline 
phosphatases: those from chicken intestine and Escherichia coli are 16.5 and 
11.1 nmol min—1 mg—1, respectively.28  While there is a great deal of 
difference between the hydrolysis of peptides and the hydrolysis of 
phosphoesters, most notably in transition state geometry, in essence they 
are both hydrolysis reactions.  The promiscuity of SgAP extends beyond mere 
hydrolysis of phosphoesters.  More interesting is the catechol oxidase 
activity.  Da Silva and Ming33 showed that SgAP was able to catalyze the 
oxidation of 3,5-di-tert-butylcatechol (DTC).  This oxidation was 
accomplished with the di-substituted Cu,Cu-SgAP, by contrast the natural 
state of SgAP is Zn,Zn-SgAP.  The enzymatic parameters given were kcat= 
1.45 s—1 and KM= 0.44 mM and kcat/KM 3295 M—1 s—1.  Which is comparable to 
a natural catechol oxidase from gypsywort ( kcat/KM 32 mM—1 s—1).33      
There is a large body of evidence that supports the claim that these 
three activities are catalyzed in the same active site.32  First, dizinc 
aminopeptidase inhibitors bestatin, 1-aminobutylphosphonate and Leu-
hydroxamate inhibit both hydrolytic activities and the oxidative activity.32,33  
Second, BNPP is shown to be a competitive inhibitor toward  Leu-pNA 
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hydrolysis.32  Finally, the activity of BNPP hydrolysis follows that of Leu-pNA 
hydrolysis on cobalt titration studies.32  Relative activity versus copper ion 
titration revealed very similar patterns for both Leu-pNA hydrolysis and DTC 
oxidation (Figure 1-2).   This indicates that as the active site that hydrolyses 
peptide bonds is completed by sequential addition of metals, so is the active 
site that hydrolyses BNPP, as is the active site for the oxidation of DTC and 
as such must be the same site. 
There are two groups of scientists that have an interest in catalytic 
promiscuity: organic chemists and evolutionary biologists.  The reasons for 
their interest are usually quite different, and as such what they qualify as 
being significant is different.  Organic chemists are most interested in 
catalytic promiscuity because they have recently discovered the ability of 
enzymes to produce stereo-selective products using a broad range of 
synthetically useful molecules.  Furthermore, the idea that small changes can 
be introduced into the enzyme’s primary sequence, which can enable a 
promiscuous reaction, can lead to even greater synthetic usefulness for the 
chemists.  This alternate catalysis of phosphoesters is of interest to chemists 
in that the phosphoester is particularly stable.  Furthermore, SgAP can  
 Figure 1-9:  Relative activity of SgAP.  DTC oxidation compared to 
Leu-pNA hydrolysis by CuII titration to apo-SgAP.  Reprinted from     
da Silva and Ming.33 
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handle high temperatures, withstanding 69 °C for 7 hours and maintaining 
approximately 80% activity,32 and so, is an enzyme that has potential for 
industrial applications. Evolutionary biologists are more concerned with what 
this catalytic promiscuity means for the natural history of this enzyme, or its 
family, which can provide a better understanding on how evolution can 
happen at a molecular level. Since the two groups have very different 
concerns or uses for catalytic promiscuity, their definition of relevance and 
focus of study are significantly different.  The more discerning of the two 
groups is undoubtedly the biologists.  They will not be concerned with a 
promiscuous reaction that occurs in vitro if it has no biological relevance in 
vivo.  Biologists have a more pressing reason to be interested with catalytic 
promiscuity.  Understanding evolution on a molecular level may become 
extremely valuable for the agricultural and medical fields.  This will aid in 
better elucidating the mechanism by which bacteria rapidly evolved to the 
pesitices and antibiotics introduced in the 20th century.   
There are two informal but important features that are crucial for this 
promiscuity.  The first is an enzyme’s plasticity, which is its ability to change 
the mechanism, binding efficiency, or substrate preference with minimal 
changes in the primary sequence.  A good example is the muconate 
lactonizing enzyme II (MLE).  A single amino acid mutation enables MLE to 
perform the o-succinylbenzoate synthase activity with high efficiency while 
retaining its muconate lactonizing activity.34  Plasticity is a common feature 
among enzymes with promiscuous activity.  The importance of plasticity in 
evolution is evident in the fact that if an enzyme requires a complete 
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modification of its primary sequence to change function, random mutation(s) 
in the sequence would be insufficient for adapting to new conditions.  The 
other important feature for an enzyme’s promiscuity is its robustness.  This is 
a way of stating that an enzyme has the ability to endure mutations with 
little impact on its native function and structure.  With promiscuous enzymes, 
the mutation(s) can result in a drastic increase in the rate of the promiscuous 
function, with little change on the rate of the original activity.35  Studies on 
robustness have defined an “x factor” as the probability that a particular 
protein will be inactivated by a single, random amino acid substitution.36  Low 
percentages define the enzyme as being highly robust.  Some reported 
examples are 3-methyladenine DNA glycolase with x factor value of           
34 ± 6%,37 T4 lysozyme ~16%,38 and barnase ~5%.39  These examples show 
that robustness can vary widely, but certain proteins can be particularly 
robust and thus are stable against random mutations.  An enzyme can 
display both robustness and plasticity.  The reason for this is simple.  Not 
every amino acid is equivalent; the location in the primary sequence as well 
as the nature of the amino acid is important.  The nature of the protein as a 
whole is also important.  If it is mostly hydrophobic residues, the probability 
that a mutation will occur at a hydrophobic residue is high.  Since the bulk of 
the naturally occurring 20 amino acids occurring in proteins are hydrophobic, 
a random mutation will probably produce another hydrophobic residue.  
Thus, the impact of mutation is minimal.  The mutation that gives rise to 
plasticity typically occurs at the amino acid(s) near the active site, and the 
effect of the change can vary from little to extreme.  In a more extreme 
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case, a simple change in the primary sequence such as a single amino acid 
alteration could result in a drastic change in substrate affinity and specificity 
and thus can be labeled promiscuous.  If the mutated amino acid is involved 
in electron transfer or shuffling, the overall mechanism may be impaired, and 
the enzyme may become less efficient or completely lose its function.   
An interesting piece of knowledge that has been discovered from the 
laboratory studies on directed evolution and promiscuity is that the 
mutations that increase promiscuous function with little effect on native 
function predominately occur on the outskirts of the active site.  In this way 
the mutation does not affect the catalytic machinery nor the scaffolding that 
holds the catalytic machinery in it’s correct orientation.  These mutations 
often occur “on surface loops that are part of the substrate binding pocket, 
and exhibit high conformational flexibility”.35   
Evolutionary biologists should be particularly interested in SgAP in that 
this appears to be a snapshot of enzyme evolution.  It was discussed earlier 
that many enzymes have a plasticity that allows for a very small number of 
mutations to result in a drastic change in promiscuous activity.35  While this 
has been able to be performed in the laboratory, SgAP appears to be rare in 
that it is a naturally occurring acquisition of promiscuous activity.  Moreover, 
it shows an example of a mutation that occurred without damage to the 
native function (i.e. robustness).   
An important target for research has been to find what amino acid 
residue(s) acts as the molecular switch.  That is what residue(s) was 
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changed that contributed to the promiscuous function or what may be 
changed to further favor one or the other.  For the biologist, the molecular 
switch in SgAP is important in that it allows one to gain a better idea of how 
evolution is working on a molecular level in a natural system.  The organic 
chemist can learn from the molecular switch by gaining a better 
understanding of how one can change other enzymes to enhance their 
promiscuous functions for stereoselective synthesis.  
Perhaps the most interesting of SgAP’s promiscuity is its catechol 
oxidase activity.  This is because the hydrolysis of peptides and the 
hydrolysis of phosphoesters are essentially very similar (they are both 
hydrolytic reactions).  That SgAP has evolved, naturally, the ability to 
perform redox chemistry, as well as maintain its hydrolytic functionality, is 
exceedingly rare and thus warrants special attention.  In all fairness, this 
redox chemistry is only present when the proper metal substitution has 
occurred.  It is, however, also fair to point out that copper ions are 
ubiquitous in biological systems.  Thus, a greater understanding of the 
mechanics of copper ions in protein systems is vital. 
1.11 Copper Chemistry 
The composition of copper in the earth crust is low (approximately 
0.7ppm).  The rarity of copper combined with its extensive use emphasizes 
the importance of its unique properties for biological systems.  On the other 
hand, a high concentration of copper ions is toxic.  This is the result of its 
inherent ability to activate molecular oxygen and create destructive reactive 
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oxygen species.  The biological usefulness of copper ions stems from its high 
redox potential, giving copper ions the ability to function as a means of 
electron transfer (i.e. plastocyanin and hemocyanin) as well as participating 
in many oxidation reactions (i.e. tyrosinase and catechol oxidase).  
Therefore, the regulation of copper ions, both in utilizing their redox 
properties as well as preventing high concentrations of free ions, is a vital 
endeavor of evolutionary processes.  
  In biological systems, copper-containing enzymes or proteins have 
been divided into three classes based upon differences in structural and 
spectroscopic characteristics.40  The first class, aptly named Type-1 copper 
centers (i.e. in blue copper proteins) are found in electron transfer proteins. 
All blue copper proteins have a similar deep blue color which is the result of 
Cys S-Cu(II) charge transfer transition with (εmax >2000 M—1 cm—1).41.  
Furthermore, the ligand environment for type-1 copper centers is consistent 
in that they position the copper into a distorted tetrahedral which is thought 
to be the transition state between the favored geometries of CuII (square 
planar or tetragonally distorted octahedral) and CuI (tetrahedral).41  One of 
the prototypical proteins of this class is plastocyanin.  Plastocyanin was 
initially discovered by Katoh.42  Early on, its involvement with photosynthesis 
was postulated in part due to previous findings by Neish43 and Green,44 which 
showed that copper was present in chloroplasts by the inhibition of 
photosynthesis when copper ion antagonists were present.  Gorman and 
Levine46 later showed that the electron transport mechanism proceeded in a 
series.  The chlorophyll of photosystem II first transfers electrons to 
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cytochrome f which then transfers them to plastocyanin and finally the 
electrons are transferred to photosystem I.  Plastocyanin, as a type-1 copper 
center, possesses certain spectroscopic properties, most notably is the 
intense absorption band at 600nm (εmax ~5000 M—1 cm—1) giving plastocyanin 
its characteristic blue color.46  It is likely that the polypeptide enforces this 
ligand environment rather than the metal ion as the metal binding site of 
apo-plastocyanin, as well as the HgII-plastocyanin isomorph retains 
essentially the same shape as the native CuII-plastocyanin metal binding 
site.46  Interestingly, while it is necessary for blue copper proteins to 
maintain the distorted tetrahedral shape, slight changes in the axial ligands 
are able to fine tune the reduction potentials as well as the reorganization 
energy to suit the particular function of their proteins.47  The plastocyanin 
from Populus nigra (black poplar), for example, has a redox potential of    
370 mV and is thus well suited for transferring between cytochrome f (redox 
potential of 340 mV) and P700+( 490 mV).  Whereas the blue copper protein 
rusticyanin from Thiobacillus ferrooxidans has a redox potential of 680 mV 
and would therefore be incapable of shuttling electrons between cytochrome 
f and P700+.47  This provides some mechanism in which evolution might 
change the polypeptide primary sequence slightly and thus affect its function 
either by changing the ligands or even by adjusting the ligands in three 
dimensional space to change the degree of distortion in the distorted 
tetrahedral.  Furthermore, it is likely that this method of fine tuning is likely 
to be applied to a greater or lesser degree in the other copper center classes. 
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 The Type-2 copper centers (i.e. the non-blue copper centers) are 
generally oxidases or oxygenases.41  The copper centers in type-2 usually 
have three to four ligands and at least one of which is the imidazole of a 
histidine49.  Cysteine, an amino acid required for type-1 copper centers, is 
absent in type-2 copper centers and thus they lack the characteristic blue 
color.  In contrast to type-1 copper centers which restrict the copper to a 
distorted tetrahedral geometry, type-2 copper centers restrict the copper to a 
distorted square pyramidal or octahedral geometry46.  This, however, is more 
of a generalization than a rule in that the geometry of a copper center is 
rarely perfectly octahedral, but rather it is often distorted to varying degrees 
due to the Jahn-Teller effect.  This is the case in CuIIZnII-superoxide 
dismutase (CuZn-SOD).  CuZn-SOD is one of the well studied type-2 copper 
centers.  This enzyme catalyzes the disproportionation reaction of superoxide 
to hydrogen peroxide and dioxygen: 
 2O2— + 2H+ ? O2+ H2O2 
Thus, CuZn-SOD enables an organism to deal with the reactive oxygen 
species (O2—) that form during cellular respiration and as a result of living in 
an oxygen-rich atmosphere.  CuZn-SOD catalyzes this reaction in a two step 
ping-pong mechanism as such:   
(1) O2—+ CuIIZnSOD ? O2+ CuIZnSOD 
(2) O2—+ CuIZnSOD + 2H+ ? H2O2 + CuIIZnSOD 
In human CuZn-SOD, the metal-binding environment of copper consists of 
four histidines (His 46, His48, His63, and His120) and a water which restrict 
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the coordination geometry to a distorted square pyramid.48  The zinc ion is 
coordinated by His63 (bridged to the Cu center), His71, His80 and Asp83 
which fill its tetrahedral coordination sphere.48  A superoxide anion, which 
has previously been nonspecifically protonated, binds the CuII center.  The 
proton, during the first transition state is exchanged for the CuII by His63.  
The superoxide then transfers a single electron to the copper, facilitating the 
CuII to CuI transition.  At this point the superoxide is oxidized to molecular 
oxygen and disassociates.  A second nonspecifically protonated superoxide 
binds to the CuI center.  This time, the CuI transfers an electron to the 
superoxide creating a hydroperoxyl anion bound to a CuII.  During the second 
transition state the proton from His63 is exchanged for CuII while the bond 
between CuII and hydrogen peroxide is broken.  This is a classic example of a 
ping-pong (double displacement) mechanism because one product (O2) is 
leaves before the second substrate (HOO•) has bound.  Most important is the 
substantial change the metal center has undertaken between the first 
substrate binding and the second substrate binding, which is accepting an 
electron and becoming CuI, providing the driving force for the second 
reaction.  The mechanism is shown in Figure 1-3.  Not all ligands are merely 
structural; for example the ligand that bridges the two metal centers (His63) 
plays an important role in being a likely source for one of the protons 
involved in the superoxide dismutation.  Furthermore, the zinc ion likely 
makes the Nε2 proton of histidine more acidic, further enhancing the overall 
activity.   
 
 Figure 1-10: Mechanism of CuZn-SOD.  Adapted from Pelmenschikov and 
Siegbahn but printed in Macpherson.48 
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The last class of copper centers, type-3, is characterized by a 
homonuclear di-copper center.  The type-3 copper-containing proteins 
generally function as oxidases or oxygenases such as catechol oxidase and 
tyrosinase, respectively and in some cases as molecular oxygen carrier 
proteins such as hemocyanin.41  Among them, tyrosinase has received 
considerable scholarly interests for a variety of reasons including its role in 
fruit browning after damage, involvement in disease states (albinism), wound 
healing and immune response, and cosmetics (inhibition of tyrosinase in 
order to lighten the skin).49  Tyrosinase has both the monooxygenase and 
catechol oxidase activity.41  It can accept a substrate with a monophenol 
moiety such as the amino acid tyrosine and add a hydroxyl group in the 
ortho position to afford a diphenolic compound, catechol.  Then, it can further 
catalyze the oxidization of catechol to the corresponding ortho-quinone.41  It 
is these quinones that are able to spontaneously polymerize to form melanins 
as the mechanism to fruit browning.41  Catechol oxidase, by comparison, 
lacks the monooxygenase activity and can only catalyze the conversion of 
catechol into ortho-quinone.41  The copper atoms in the type-3 center are 
antiferromagnetically coupled with a ground state of S = 0 in the presence of 
molecular oxygen (in the reduced form) or hydrogen peroxide (in the 
oxidized form).41  Upon binding, the di-copper center adopts the oxy-state 
with absorbance maxima at 340 nm and 580 nm caused by O2—2 to CuII 
charge transfer transition.  The deoxy state which contains CuI:CuI is 
diamagnetic.43  Both copper sites in the tyrosinase from Streptomyces 
castaneoglobisporus crystallized by Matoba et al.51 are each coordinated to 
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three histidine residues at the Nε atom.  This histidine rich coordination 
sphere is a similar feature for all type-3 copper centers including catechol 
oxidase and hemocyanin.49   The mechanism by which tyrosinase oxidizes a 
monophenol through the catechol-moiety to ortho-quinone is complex, and a 
definitive mechanism is still under debate.  In one example, the monophenol 
binds the oxy-state and is monooxygenated.  The catechol-moiety is then 
free to disassociate.  A catechol-moiety can bind the met-state copper center 
and is oxidized to o-quinone, leaving the copper center in the deoxy-state.  
The deoxy-state binds molecular oxygen to reestablish the initial oxy-state.41   
This mechanism is shown in Figure 1-11.  Another proposed mechanism is 
similar except that once the monophenol binds the copper center it does not 
disassociate until it is o-quinone.49  This mechanism is shown in Figure 1-12. 
Given the ability of SgAP to perform catecholase activity it is clear that 
it shares more common features with a type-III CuII center.  Thus a 
comparison of the active sites of tyrosinase and SgAP could provide useful 
information in looking for the molecular switch to enhance catecholase 
activity (Figure 1-13).  An obvious difference is the composition of the active 
site.  In tyrosinase the ligands are all His residues, while in SgAP a blend of 
acidic residues and His residues is present.  Thus, potential targets for 
enhancing catecholase activity in SgAP would be Asp-97, Asp-160 and Glu-
132. 
In searching for the molecular switch for switching between the 
hydrolysis reactions, the most obvious place to start looking was where  
 Figure 1-11:  Mechanism for tyrosinase.  Starting from mono-phenol 
moiety through quinone.41  This displays the theory that the intermediate 
catechol is released and then subsequently rebound. 
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 Figure 1-5:  Alternative mechanism for tyrosinase.  This mechanism 
does not allow the relase of the catechol moiety but rather continues through 
to the final quinine as championed by Decker et al.49 
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 Figure 1-13:  Comparison of metal centers of SgAP and tyrosinase.  
Side by side comparison of SgAP27 (Left) and tyrosinase from Streptomyces 
castaneoglobisporus (Right).49 
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Harris et al.26 showed a likely phosphate binding moiety.  This is because the 
alternate substrate, BNPP, has a phosphate and it is the phosphoester that is 
cleaved in the promiscuous function.  As such, places where phosphate could 
bind would make ideal candidates.  The NMR studies, as well as phosphate 
inhibition studies (showing that phosphate was a noncompetitive inhibitor), 
indicated that the most likely candidate would be the Arg residue near the 
active site, Arg202.26  Harris was able to use chemical methods to modify the 
Arg and found that kcat decreased and the Km increased significantly toward 
Leu-pNA.  Also the Ki for phosphate inhibition increased as well.  These 
results indicate that the phosphate and the Leu-pNA interact with the Arg-
202.26  The chemical modification can be manipulated in such a way to 
protect certain Arg residues.  By incubating SgAP in a buffer with phosphate 
before and during the modification step those Arg that are binding phosphate 
should be protected.  Following modification the sample with phosphate 
protection showed little change in activity, thus Arg-202 when unprotected 
was changed and a decrease in activity was seen.  Furthermore, protection 
with 1-aminobutylphosphonate, which binds at the active site, indicates that 
the important Arg is also close to the active site, and the best candidate is 
Arg202.  The problem with using chemical methods to modify an amino acid 
is that it is difficult to be selective.  It is usually impossible to modify a single 
amino acid, especially in a protein with as many residues as SgAP.  As such, 
the possibility that an amino acid, similar but separate, to the intended 
target was modified and it is this change that is responsible for observed 
results (in SgAP there are 8 arginine residues that could be changed).  For 
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this reason molecular biology has been employed in this research dilemma.  
Through site-directed mutagenesis biologists are able to change one amino 
acid to another, delete an amino acid or add an amino acid at the DNA level.  
This, unlike chemical modifications, is absolutely specific leading to a change 
only as specified.  The goal of current research is to understand the 
molecular mechanisms of this hydrolysis reaction.  This will be accomplished 
through the exploitation of molecular biology techniques to determine what 
the functions of the active site residues are.  
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Chapter II:  SGAP MATERIALS AND METHODS   
2.1 SgAP in Escherichia coli expression system 
Isolating insert DNA from Streptomyces coelicolor 
 The Streptomyces coelicolor genome was purchased from ATCC.  The 
primers used were 5-AAT CCC GGG TAG GCG ACA GTT CCC AGA C-3’ and 5’-
/5PHOS/AAC GTC AAG GCC CAT CTG AGG-3’ and purchased from Integrated 
DNA Technology (IDT).  The reagents for use in the polymerase chain 
reaction (PCR) were purchased from Promega.  The PCR was performed on 
an Eppendorf Mastercycler Gradient.  The PCR products were purified using 
Amicon Spin Columns from Millipore.  Agarose gel electrophoresis was 
utilized to confirm the PCR was successful.  For a detailed protocol please see 
Appendix A. 
Cloning 
 The vector, pQE30Xa, was purchased from Qiagen.  This vector 
contains the gene for ampicilin resistance as well as a C-terminal 6x-His tag 
and a peptide sequence recognized by Factor Xa protease for removing the 
His-tag and has an approximate size of 3.5 kb.  The pQE30Xa was digested 
with XmaI and StuI (both purchased from New England Biolabs).  The 
purified PCR product insert was digested with only XmaI (as the PCR product 
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was designed with a blunt end that would anneal with the blunt end created 
by StuI).  Following digestion both reactions were quenched by denaturing 
the restriction endonucleases at 65 °C for 10 minutes.  The DNA products 
were then purified using Amicon Spin Columns.   
The digested vector was then treated with shrimp alkaline 
phosphatase, purchased from Promega. The use of shrimp alkaline 
phosphatase removes phosphates on the vectors digested ends that could 
provide the necessary energy to self-ligate.  Self-ligation is unlikely because 
the ends were incompatible; however, by removing the phosphates with 
shrimp alkaline phosphatase the reaction is effectively impossible.  Again, the 
DNA product from shrimp alkaline phosphatase was purified using Amicon 
Spin Columns.  
 Ligation materials were purchased from Promega.  The ligation 
reactions were carried out at various ratios of vector to insert (1, 2, 3, 5, 10, 
15, 20, 50, 100, and 150).   Of which, success was achieved with a 20:1 
vector to insert ratio.  The ligation reaction product was used to transform 
XL1-blue E. coli.  This bacterial cell line is transformed using heat shock 
technique and was then plated on LB-Amp (100 ug/mL ampicilin) plates and 
grown overnight at 37 °C.   
Successful colonies were picked and transferred to a 3 mL liquid LB-
Broth and shaken overnight at 300 rpm at 37 °C.   This liquid culture was 
then tested for possessing a vector with approximate size of 4.5 kb (vector 
and insert) using a crude mini-prep (reagents from Qiagen) and then agarose 
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gel electrophoresis.  Those that appeared to have said band were then 
digested with PstI and EcoRI to separate the insert from the vector (XmaI 
was not used because it is unnecessarily expensive and the EcoRI and PstI 
cut sites are close enough to not be noticed on agarose gel electrophoresis.  
Successful ligations following digestion would have two bands, one 
representing the vector with an approximate size of 3.5 kb and one 
representing the insert with an approximate size of 1 kb.  More liquid 
cultures for colonies that passed the digestion test were produced, their 
vector DNA purified using a perfect prep (kit purchased from Qiagen) and 
then sent to Macrogen, USA for sequencing.  The sequencing primers used 
were: 5’-AAG CGC AGG TGC TTC GTC GG-3’ and 5’-ATC TGA GGC AGC TGG 
AGT CGA TCG-3’.  For detailed protocols see Appendix A. 
Expression of Recombinant Protein 
 Expression was induced using Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) purchased from Fisher BioTech. 
A quick expression test was used to determine which of the 
successfully ligated colonies was producing more protein than the others.  
The colony that appeared to be producing the most recombinant protein 
(with an approximate MW of 30 kDa) was then selected for future use, while 
glycerol stocks of it as well as the other colonies were stored in –80 °C 
storage.   
 Expression was further tested to determine if temperature, IPTG 
concentration, and time would affect whether or not the protein was in the 
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soluble or insoluble fractions after the cells were lysed and the fractions 
separated.  Expression could be observed via SDS-PAGE or Western Transfer.  
See Appendix A for detailed protocols. 
Purification of Recombinant Protein 
 Purification of recombinant proteins was performed using an affinity 
column utilizing the His-tag engineered into the protein by the pQE30Xa 
vector.  The His-tag strongly binds Ni-NTA Agarose (purchased from Qiagen).  
The insoluble fraction was made soluble using a urea buffer or a guanidium 
HCl buffer (which proved cost prohibitive and not effective enough to justify 
its continued use).  The Ni-NTA Agarose was added to this solution (urea 
buffer and insoluble fraction) and subsequently passed through a column 
which was then washed and eluted using a pH gradient.  Purification could be 
observed on via SDS-PAGE or Western Transfer.  See Appendix A for detailed 
protocols. 
Refolding of Recombinant Protein 
 Several attempts were made to refold the recombinant protein and 
gain activity.  In most cases dialysis using Spectra/Por dialysis tubing 
purchased from Spectrum having a molecular weight cut-off of 6000-8000 
daltons was utilized.  Various methods of stepping down the urea 
concentration to induce folding spontaneously, as well as greatly diluting the 
concentration of protein to assist with refolding, were attempted.  Following 
refolding protocols, concentrating the product was accomplished using an 
affinity column and Ni-NTA agarose or using YM-10 membrane and Amicon 
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Concentrator.  Experiments were performed using reducing agents to reduce 
the disulfide bonds.  Detergents using Tween-20 or Triton X-100 were used 
in different experiments to see if this could dissolve the inclusion bodies and 
then removing the detergent with Bio-Beads SM-2 Adsorbents from Bio-Rad.  
Including acetone in the refolding buffers was attempted.  Refolding 
experiments were attempted with ZnII, CaII, both, or neither.  All relevant 
protocols can be found in Appendix A. 
  Following refolding protocols a sample was tested for peptidase 
functionality using Leucine-para-nitroaniline (L-pNA) in pH 8.0 100 mM       
4-(2-hydroxyethyl)-1-piperazineethanesulfonate (HEPES ) buffer with 2 mM 
Ca(NO3)2.  Activity was monitored at 405 nm.  Another sample from the 
refolding product was treated with Factor Xa protease to remove the His-tag 
and then purified using Amicon Spin Columns.  Following purification the 
sample was again tested for peptidase activity.  This was performed to 
ensure that the His-tag was not affecting peptidase activity.  Protocols may 
be found in Appendix A. 
2.2 ScAP in Streptomyces lividans system 
Isolating Insert DNA from pUC57 
 Following the example set by Ni et al.52 the gene was designed to 
include the pre-pro sequence from Streptomyces limosus α-amylase and 
Streptomyces griseus protease B.  This designed gene was custom made by 
Genescript and delivered in the pUC57 vector.  The pUC57 vector was 
transformed into XL1-Blue E. coli and grown on LB-Amp plates.  One 
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successfully transformed colony was then picked and used to inoculate a   
500 mL LB-Amp broth in order to be used with a Maxi-Prep (Qiagen) to 
isolate large quantities of the pUC57 vector (with the gene of interest).  The 
pUC57 vector was then digested using NcoI and SacI.  This separated the 
vector DNA from the insert (gene of interest) DNA.  The vector DNA and 
insert DNA were then separated using agarose gel electrophoresis.  The 
agarose was then separated from the DNA using MO-BIO’s Ultraclean Gel 
Spin Kit.  All relevant protocols can be found in Appendix B. 
Cloning 
 The vector used for expression in S. lividans, pD730, as well as a 
sample of S. lividans was graciously received from Dr. David Wilson, Ph.D 
and Dr. Diana Irwin, Ph.D from Cornell University.  This vector required a 
total digest with SacI and a partial digest with NcoI.  Following digestion the 
vector was separated using agarose gel electrophoresis and MO-BIO’s 
Ultraclean Gel Spin Kit.   
 The pD730 vector was treated with shrimp alkaline phosphatase and 
then purified using Amicon spin columns.  A ligation reaction was then 
carried out to ligate the gene of interest to the new vector.  The ligation 
reaction product was then used to transform XL1-Blue E. coli which were 
grown overnight at 37 °C on LB-Amp plates.  Successfully transformed 
colonies were then used to inoculate 3 mL cultures to be used in a crude 
mini-prep.  Samples from the crude mini-prep that displayed bands on an 
agarose gel corresponding to approximate size of 8 kb were considered 
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candidates for the digestion.  Upon digesting with SacI a successfully ligated 
vector and insert construct would have a band 1 kb larger than the vector 
alone.  These were then selected and sent to MWG sequencing.  Four 
sequencing primers were utilized.  Two of the primers would bind outside the 
gene of interest, on the vector, which would sequence into the gene.  These 
primers were 5’-TCG AAT CCT GCG GAA GGA G-3’ and 5’-GGT ACC GCA TGC 
CAT ATG GA-3’.  The other two primers would bind inside the gene of interest 
and sequence out towards the vector DNA.  These primers were 5’-ACA CGA 
GTC GTG AAG CC-3’ and 5’-GGG TTA CTT CGT CTA GGA CG-3’.  After 
sequencing it was apparent that the gene would be sequenced out of frame.  
As such site directed mutagenesis primers were designed to delete a single G 
nucleotide, thus putting the entire peptide back into frame.  These primers 
were 5-CCT GCG GAA GGA GCC CCA CCA TGA TGC GCA TCA AGC GGA CC-3’ 
and 5’-GGT CCG CTT GAT GCG CAT CAT GGT GGG GCT CCT TCC GCA GG-3’.  
Site directed mutagenesis was performed using reagents from QuikChange II 
from Stratagene.  All relevant protocols can be found in Appendix B. 
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Chapter III: SGAP RESULTS AND DISCUSSION 
At the time when this project was started the exact genomic sequence 
of Streptomyces griseus aminopeptidase (SgAP) was unknown.  As such 
designing primers in order to use PCR to extract the insert from the S. 
griseus genome was not possible.  In retrospect, there is the potential to use 
“degenerative primers” for PCR.  Essentially, a primer for every possible 
combination of codons is created and the mix used for PCR.  Whichever of 
the combinations is the successful will bind and produce the desired inserts 
while the incorrect ones will not bind and not produce insert fragments.  That 
said, there are obvious cost issues, as well as further complications from 
having competing primers.  The genome of Streptomyces coelicolor was 
known, however, and it had previously been shown to have a putative 
aminopeptidase similar to SgAP.  Moreover, the active sites in both enzymes 
were identical, and as such the promiscuous activity seen in SgAP is likely to 
also occur in ScAP.  Thus, ScAP became the target because the DNA 
sequence was known and primers for PCR could be designed to isolate the 
ScAP gene while they could not currently be designed to isolate the SgAP 
gene.  Running the PCR product on a 0.7% agarose gel (Figure 3-1) clearly 
shows that the PCR produced a gene with an approximate size of 900 bp, the 
appropriate size for the target insert.    
  
  
 
 
 
 
 
 
 
Figure 3-1:  0.7% agarose gel of the product of PCR Reaction.  The 
bright bands are situated well between the 750bp and 1kb bands on the 
molecular weight marker 
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Following ligation 28 of the successfully grown colonies were picked 
and grown in liquid cultures and their vector DNA isolated using a crude mini 
prep protocol.  This vector DNA was run on an agarose gel to determine the 
size of the recombinant vector and compare that size with the pQE-30 Xa 
vector.  The insert DNA having a size of 900 bp and the pQE-30 Xa vector 
having a size of 3.5 kb it would be possible to see a difference between the 
4.5 kb construct (vector and insert) from the vector itself (Figure 3-2). 
Crude mini prep products that exhibited an upward shift and the pQE-
30 Xa were digested with EcoRI (located just before the His-tag of pQE-30 
Xa) and PstI (part of the multiple cloning site of pQE-30 Xa).  EcoRI and PstI 
were chosen instead of XmaI and StuI for fiscally responsible reasons (XmaI) 
and because the cut site is not present after the blunt end ligation (StuI).  If 
the insert were in the construct a band of approximately 900 bp would be 
seen.  If, however, there were no insert no DNA would appear below the 
vector band because the lost DNA would be too small to appear on an 
Agarose Gel (Figure 3-3). 
Colonies 13, 16, 17 and 22 were processed through a perfect prep and 
the product DNA sent to Macrogen for sequencing.  Of which colony 16 
proved the most successful (Figure 3-4 through Figure 3-6). 
 
  
 Figure 3-2:  0.7% agarose gel of the product of the crude mini 
prep.  The last lane in both levels of the gel represents the vector by 
itself  (pQE-30 Xa) in order to be compared to the products of the crude 
mini prep.  Lanes with the construct would exhibit an upward shift.  Lanes 
labeled 3, 9, 10, 11, 15, 16, 17, 22 and 25 exhibit potential and so were 
selected for further processing. 
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 Figure 3-3:  EcoRI and PstI digest of crude mini prep product and 
pQE-30 Xa vector.  Clearly samples 9, 10, 11, 13, 15, 16, 17, and 22 
have the appropriate band at 1kb.  The band is not at 900bp as was said 
before, but this likely is the result of slight increased from cutting at 
EcoRI and PstI rather than XmaI and StuI.  
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GGCAGACAGCTCGCTATTAGCTTGGCTGCAGGTCGACCCGGGTAGCGACAGTTCCCAGA
CCGCGTAGGCGATGGCGTCGCTGTTGCGGTCCAGGGCCGTGTCGTCGATGTTGGCGGTC
GTGTCGCAGGACGAGTGGTAGCAGCGGTCGAAGGGCTGGCCCACGGTGCCGCCCCACTT
GGCCGCCTGCGCGGACGTCTTGCGGTAGTCCGCGCCGCTGAAGAGGCCGCCCACGGGGA
CGCCCGCGTTCTTGAAGGGTGCGTGGTCGGAGCGTCCGTCGCCCTCGGTCTCGATCTCC
GTGGAGATGCCGATCCCGCTGAAGTAGTCCTTGAACGTCTTCTCGATCGTGGGATCGTC
GTCGTAGACGAAATAGCCGGGGTTGGGCGAGCCGATCATGTCGAAGTTCAGGTAACCGC
TGATCTTCGCGCGTTCCGCGGAGCCGAGGCTGTTGACGTAGTAGCGGGAGCCGACGAGT
CCCAGCTCCTCCGCGCCCCACCAGGCGAAGCGCAGGTGCTTCGTCGGCTGGTAGCCGGA
CCGGGCGACGGCGAGCGCGGTCTCCAGGACGGCCGAGGAGCCGGAACCGTTGTCGTTGA
TGCCGGGCCCGGAGGCGACACTGTCCAGATGTGACCCGGCCATGACAATCTGACTCGCG
TCGCCGCCGGGCCAGTCGGCCGTCAGGTTGTACCCGGTGCGGCCCGAGGCGCTGAACTG
CTGGACGCGGGTGGTGAACCCGGCGGCGTCCAGCTTGGCCTTCATGTAGTCGAGGGAGG
CCCGGTAGCCGGCGCGGCCGTGGGCGCGGTTGCCGCCGTTCGCCGTGGCGATCGACTCC
AGCTGCCTCAGATGGGCCTTGACGTTCCTTCCCTCGATACCAGATCCAGAGCCAGATCC
GTGATGGTGATGGTGATGCGATCCTCTCAT 
 
Figure 3-4:  Sequencing results from Macrogen. 
 
 
MRGSHHHHHHGSGSGSGIEGRNVKAHLRQLESIATANGGNRAHGRAGYRASLDYMKAKL
DAAGFTTRVQQFSASGRTGYNLTADWPGGDASQIVMAGSHLDSVASGPGINDNGSGSSA
VLETALAVARSGYQPTKHLRFAWWGAEELGLVGSRYYVNSLGSAERAKISGYLNFDMIG
SPNPGYFVYDDDPTIEKTFKDYFSGIGISTEIETEGDGRSDHAPFKNAGVPVGGLFSGA
DYRKTSAQAAKWGGTVGQPFDRCYHSSCDTTANIDDTALDRNSDAIAYAVWELSLPG 
STCSQANSELSA 
 
Figure 3-5:  Translation of sequence results from Macrogen.  Bold and 
underlined areas are the result of the vector.  This sequence gives a protein 
with an estimated molecular weight of 32.27kDa. 
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16   MRGSHHHHHHGSGSGSGIEGRNVKAHLRQLESIATANGGNRAHGRAGYRASLDYMKAKLD  
ScAP --------------APDIPIANVKAHLRQLESIATANGGNRAHGRAGYRASLDYMKAKLD 
        ---------------------*************************************** 
16 AAGFTTRVQQFSASGRTGYNLTADWPGGDASQIVMAGSHLDSVASGPGINDNGSGSSAVL  
ScAP AAGFTTRVQQFSASGRTGYNLTADWPGGDASQIVMAGSHLDSVASGPGINDNGSGSSAVL  
 ************************************************************ 
16 ETALAVARSGYQPTKHLRFAWWGAEELGLVGSRYYVNSLGSAERAKISGYLNFDMIGSPN  
ScAP ETALAVARSGYQPTKHLRFAWWGAEELGLVGSRYYVNSLGSAERAKISGYLNFDMIGSPN  
 ************************************************************ 
16 PGYFVYDDDPTIEKTFKDYFSGIGISTEIETEGDGRSDHAPFKNAGVPVGGLFSGADYRK  
ScAP PGYFVYDDDPTIEKTFKDYFSGIGISTEIETEGDGRSDHAPFKNAGVPVGGLFSGADYRK  
 ************************************************************ 
16 TSAQAAKWGGTVGQPFDRCYHSSCDTTANIDDTALDRNSDAIAYAVWELSLPGSTCSQAN  
ScAP TSAQAAKWGGTVGQPFDRCYHSSCDTTANIDDTALDRNSDAIAYAVWELSQ---------  
 **************************************************----------           
16 SELSA  
ScAP ----- 
 
Figure 3-6:  ClustalW2 alignment of colony 16 translation result 
aligned with ScAP. 
  
  
 
 
 
 
   
 
 
 
 
 
 
  
 
 
 
 
 
Figure 3-7:  Successful purification.   MW= molecular weight marker, C1, 
C2, D, and E coorespond to washes and elutions as discussed in protocols in 
Appendix A.  FT= Flow through. 
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Clearly, based upon the sequencing data, the translation of it, and its 
alignment with ScAP the cloning was successful.  As such colony 16 became 
the focus for expression, purification and refolding attempts.  
Based upon the purification shown in Figure 3-7, it is evident that 
purification was successful, however, so much protein is being produced that 
all the Ni-NTA agarose used during the purification process is saturated with 
His-tagged protein and thus the excess His tagged protein is lost in the flow 
through and wash steps.  Thus indicating that more Ni-NTA agarose should 
be used in future purifications.  After another successful purification, dialysis 
was performed on the E fraction to remove the denaturant so that the 
protein might refold spontaneously.  After multiple changes of the dialysis 
buffer a precipitate formed and coated the dialysis bag but was easily 
dislodged into the dialysis buffer.  Centrifugation separated the dialysis buffer 
from the precipitate and samples of both supernatant and precipitate were 
taken, and mixed with 2x SDS-PAGE buffer.  The results of which are shown 
in Figure 3-8. 
 
 
 
 
 
  
 
 
 
 
 
Figure 3-8:  Failed refolding protocol due to precipitation.  MW = 
molecular weight, E= fraction E before dialysis, S= dialysis supernatant, P= 
dialysis precipitate.   
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Unfortunately, the majority of the protein seemed to have been in the 
precipitate.  Furthermore, the little protein that remained in the supernatant, 
upon concentrating through a YM-10 membrane showed no activity with Leu-
pNA.  Regarding the identity of the second band in the E fraction it seems 
possible that it is the result of some proteolytic cleavage of ScAP during 
purification possibly by some enzyme native to E. coli, or another unknown 
phenomenon. 
After trying unsuccessfully many times to refold the protein and 
achieve activity it was found that expression at 25.7 °C and 0.1 mM IPTG 
shifted some of the expressed protein to the soluble fraction (while the 
majority still was in the insoluble fraction).  The purification proved 
challenging however, as shown in figure 3-9. 
 Purification of the soluble fraction was never achieved to the level that 
was attained by the insoluble purification.  Nonetheless, the elution fractions 
were tested for aminopeptidase activity against Leu-pNA but activity was not 
detected.  To ensure that this was not due to the His-tag Factor Xa was 
utilized to remove the His tag.  To ensure the removal of the His tag a 
Western blot was used. 
The western blot clearly shows that the His tag was removed by Factor 
Xa (Figure 3-10).  The Factor Xa protease reaction dilutes the sample by half, 
and given the sensitivity of the Western blotting technique it is impossible to 
have the quality bands we have in the untreated lanes and nothing in the  
  
 
 
 
 
 
Figure 3-9:  Purification from soluble fraction.  From Left to right: 
MW, Wash 1, Elutions 1 though 4.  The dark band on the bottom is 
lysozyme, a byproduct of the purification and lyses of the cellular wall 
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 Figure 3-10:  Western blot results from soluble purification and 
Factor Xa.  A side by side comparison of the SDS-PAGE Gel, and a western 
blot attained from an identical gel.  Lanes in both (from right to left) 
correspond to: Molecular weight marker, Wash 1, Elutions 1 through 4, 
4Units Factor Xa 2 hours, 4Units Factor Xa 3 hours, 10U Factor Xa 2 hours, 
10U Factor Xa 3 hours, 20U Factor Xa 2 hours, 20U Factor Xa 3 hours. 
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treated bands based simply upon a 50% reduction.  As for the smaller bands 
that show up in the last three elution samples it is likely that these are the 
result of proteolytic cleavage during the purification process by an unknown 
peptidase.  The new bands shown in the treated lanes represent the Factor 
Xa.  Factor Xa is 44kDa, however this is really two polypeptides connected by 
a disulfide bond. 
The SDS-PAGE loading dye reduces the disulfide bond thereby 
separating the larger polypeptide from the smaller one, hence the large band 
at approximately 30 kDa and the smaller band above the lysozyme band.  
Testing the Factor Xa treated samples with Leu-pNA revealed no activity. 
Following months of attempts to get the insoluble fraction to refold to 
an active enzyme and the lack of activity with the soluble fraction enzyme it 
became apparent that the possibility that the protein cannot fold correctly in 
E. coli should be investigated.  An article by Henderson et al55 compared two 
putative enzymes from S. griseus that revealed that the propeptide is likely 
vital for secretion of proteases in S. griseus.  Given that SgAP is a putative 
enzyme it too must have a propeptide region, although neither DNA nor 
amino acid sequence has yet been published.  Furthermore, a fully folded 
protein is not able to be secreted as it cannot diffuse through the plasma 
membrane.  Therefore, in the case of S. griseus the protein does not fold in 
the cytosol of the bacteria but rather folds as it is excreted in the medium in 
which the bacteria is growing.  Moreover, the protein may not fold correctly 
as it is translated on the ribosome, that is, in S. griseus with the propeptide 
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sequence intact, chaperone proteins bind and prevent folding and so the first 
sequences to be translated might not fold until later parts have been able to 
fold.  The active conformation may not be the lowest potential energy, but 
rather located in an energy trough the result of folding in a particular order.   
In the E. coli expression system used herein, the peptide lacks a 
propeptide sequence and furthermore given the very different physiology of 
S. griseus and E. coli the propeptide sequence from S. griseus may not have 
any corresponding chaperone proteins in E. coli.  As such, expressing ScAP in 
an expression system more closely related to the native system may yield 
more positive results.  One technique for doing this was published by Ni et 
al52 in which they expressed and purified recombinant Streptomyces griseus 
in S. lividans.  As the propeptide sequence was unknown Ni et al. designed 
their own using the amino terminus of the signal peptide from S. griseus 
protease B and the carboxy terminus of the signal peptide from S. limosus 
alpha-amylase.  The exact sequence of the propeptide sequence of Ni et al. 
was not published, however, a propeptide sequence using hints in their 
article was put together (Figure 3-11).   
 The construct sequence for rScAP was received in a plasmid and thus 
required digestion the use of agarose gel separation and purification (Figure 
3-12).   
 The vector pD730 was generously supplied by Dr. David Wilson and 
Dr. Diana Irwin from Cornell University.  pD730 is designed for multiplication 
in both E. coli and S. lividans but only for expression in S. lividans.  In  
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SgPB signal peptide53 
MRIKRTSNRSNAARRVRTTAVLAGLAAVAALAVPTANA 
 
Alpha Amylase signal peptide54 
MARRLATASLAVLAAAATALTAPTPAAAA 
 
ScAP 
APDIPIANVKAHLRQLESIATANGGNRAHGRAGYRASLDYMKAKLDAAGFTTRVQQFSASGRTGY
NLTADWPGGDASQIVMAGSHLDSVASGPGINDNGSGSSAVLETALAVARSGYQPTKHLRFAWWGA
EELGLVGSRYYVNSLGSAERAKISGYLNFDMIGSPNPGYFVYDDDPTIEKTFKDYFSGIGISTEI
ETEGDGRSDHAPFKNAGVPVGGLFSGADYRKTSAQAAKWGGTVGQPFDRCYHSSCDTTANIDDTA
LDRNSDAIAYAVWELSQ 
 
Construct 
MRIKRTSNRSNAARRVRTTAVLAGLAAVAALTAPTPAAAAAPDIPIANVKAHLRQLESIATANGG
NRAHGRAGYRASLDYMKAKLDAAGFTTRVQQFSASGRTGYNLTADWPGGDASQIVMAGSHLDSVA
SGPGINDNGSGSSAVLETALAVARSGYQPTKHLRFAWWGAEELGLVGSRYYVNSLGSAERAKISG
YLNFDMIGSPNPGYFVYDDDPTIEKTFKDYFSGIGISTEIETEGDGRSDHAPFKNAGVPVGGLFS
GADYRKTSAQAAKWGGTVGQPFDRCYHSSCDTTANIDDTALDRNSDAIAYAVWELSQIEGRHHHH
HH  
 
Figure 3-11:  Construct sequence for Recombinant ScAP (rScAP) to 
be expressed in S. lividans.  The Grey area represents the Factor Xa cut 
sequence as well as the His-tag for purification purposes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 3-12:  rScAP digest out of pUC57 vector as shown on 0.7% 
Agarose Gel 
 Lane 1:  Molecular Weight Marker (From bottom: 500 bp, 1 kb,        
 1.5 kb, 2.0 kb, 3.0 kb, 4.0 kb, 5.0 kb, 6.0 kb, 8.0 kb, 10.0 kb) 
 Lane 2:  pUC57 (supercoiled and nicked circular) 
 Lane 3:  pUC57 Digested with SacI 
 Lane 4:  pUC57 Digested with SacI and NcoI. 
    Insert is lower band with ~1000bp 
 Lane 5:  Purified product of Insert (faint but present and the  
   concentration can be determined using A260 
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preparation for ligation it needed to be digested and the correct fragment 
separated by agarose gel electrophoresis and purified from the gel (Figure 3-
13).  The vector pD730 had to be subjected to a partial digest protocol 
because it had various NcoI recognition sequences.  The fragment required 
for ligation had a size of 7619 bp while the entire vector has a size of 7654 
bp.  As such, there would be no way to separate them, however, the 
incorrectly cut fragments would all be considerably smaller, the closest of 
which would be 6.3 kb.  The highest band on the gels with the double cuts is 
a mixture of two populations, the first a single cut vector, and a double cut 
(correct two cuts).  The ratio between these two populations depends on the 
amount of time exposed to NcoI and as such for purification out of the gel 
the 20 minute sample was chosen.  It appears that 2 hours of exposure to 
the second restriction enzyme is enough to remove the residual uncut vector 
there should therefore be no difference in population between the 20 min 
NcoI/2 hour SacI and the 20 min NcoI/24 hour SacI top bands.  As such 
purification was chosen on the 20 min NcoI/2 hour SacI sample and the 
concentration was determined by A260.   
 Ligation with the vector should not prove a difficult situation despite 
the vector being a mixed population of single cut vectors and correctly 
double cut vectors.  The logic behind this is first that the insert can only 
ligate with a correctly cut vector due to compatibility issues between the 
ends.  Secondly, the vector is treated with Calf intestinal alkaline 
phosphatase.  This removes the phosphates from the 5’ ends of the DNA  
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 3-13:  Partial digest of pD730 on a 0.3% Agarose gel. 
Lane 1: Molecular weight marker (From bottom 500 bp, 1.0 kb,      
1.5 kb, 2.0 kb, 3.0 kb, 4.0 kb, 5.0 kb, 6.0 kb, 8.0 kb, 10.0 kb) 
Lane 2: uncut pD730.  
Lane 3: pD730 digested with Sac. 
  Lanes 4-6: 10min exposure to NcoI with varied exposure to SacI. 
 Lanes 7-9: 15min Exposure to NcoI with varied exposure to SacI. 
 Lanes 10-12: 20min Exposure to NcoI with varied exposure to SacI. 
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which prevents easy self ligation.  This prevents the vector from self-ligating 
and therefore becoming a working vector that can transform bacteria but 
yields no value due to the lack of an insert.   
 Successfully transformed bacteria that grew on LB-Amp agar plates 
were grown in liquid broth cultures and their DNA extracted and digested 
with SacI.  The product of was run on an agarose gel and is displayed on 
Figure 3-14.  While in no way is the Figure 3-14 gel perfect, especially when 
compared to above Figure 3-12 and Figure 3-13, it is not used by itself to 
determine which bacterial conlonies were successfully transformed.  
Sequencing is the only way to truly determine if ligation was successful as it 
will also show if the sequence is in frame and if expression will proceed 
correctly.  The determined sequence is shown in Figure 3-15. 
 The translation from colony five did not code for the rScAP as 
expected, Figure 3-16.  Upon evaluation of the Sequencing DNA the reason 
for this becomes apparent in that the G as highlighted in Figure 3-15 is extra, 
a byproduct of engineering an NcoI cut site so the insert could be used with 
pD730.  This extra G nucleotide throws the sequence out of frame.  At the 
time of writing this our laboratory is currently working on eliminating this 
extra G nucleotide, the new translation of which is expected to push 
eliminate the frameshift.  The translation of the expected sequence without 
the extraneous G is shown in Figure 3-17, and the alignment with the 
designed construct (figure 3-11) is shown in Figure 3-18.  
 
 
  
Figure 3-14:  Crude Mini prep digested with SacI.  Dark horizontal line 
indicates furthest region the Vector lane reached.  Samples with band above 
this line may have insert ligated and are selected for sequencing.  Therefore, 
samples 2, 5 and 15 were chosen. 
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TCCAGCGGAAGGAGCCCCACCATGGATGCGCATCAAGCGGACCTCCAACCGCAGCAACG
CCGCGCGCCGAGTCCGCACCACGGCGGTCCTGGCGGGACTCGCAGCAGTGGCAGCATTG
ACCGCCCCCACCCCGGCGGCGGCGGCGGCACCGGACATCCCGATCGCGAACGTCAAGGC
CCACCTCCGGCAGCTCGAGAGCATCGCGACCGCCAACGGAGGCAACCGGGCCCACGGCC
GTGCGGGTTACCGGGCCTCGCTCGACTACATGAAGGCGAAGCTGGACGCCGCCGGCTTC
ACGACTCGTGTGCAGCAGTTTAGCGCGTCGGGCCGTACCGGGTACAACCTGACCGCCGA
CTGGCCCGGCGGCGACGCGTCCCAGATCGTGATGGCCGGGAGCCACCTCGACTCGGTGG
CTTCCGGCCCCGGTATCAACGACAACGGCTCCGGCAGTAGCGCCGTCCTGGAGACGGCG
CTGGCGGTCGCCCGATCGGGTTACCAGCCGACCAAGCACCTCCGGTTCGCCTGGTGGGG
CGCGGAGGAGCTGGGCCTGGTCGGCTCCCGGTACTACGTCAACTCGCTGGGCAGCGCCG
AGCGCGCCAAGATCAGCGGGTACCTGAACTTCGACATGATCGGCTCCCCGAACCCGGGT
TACTTCGTCTACGACGACGACCCGACGATCGAGAAGACCTTCAAGGACTACTTCTCCGG
GATCGGCATCTCCACGGAGATCGAGACCGAGGGCGACGGACGCTCCGACCACGCACCCT
TCAAGAACGCGGGAGTCCCGGTCGGCGGCCTGTTCAGCGGCGCCGACTACCGCAAGACC
TCCGCGCAGGCGGCCAAGTGGGGCGGCACTGTCGGCCAGCCCTTCGACCGCTGCTACCA
CTCCAGTTGCGACACCACGGCCAACATCGATGACACGGCCCTGGACCGTAACAGCGACG
CCATCGCATACGCCGTCTGGGAGCTGTCGCAGATCGAGGGCCGGCATCACCACCACCAC
CACGGTACC 
Figure 3-15:  Sequencing DNA from Colony 5 using internal and 
external sequencing primers. 
 
SSGRSPTMetDAHQADLQPQQRRAPSPHHGGPGGTRSSGSIDRPHPGGGGGTGHPDRERQGPPPA
AREHRDRQRRQPGPRPCGLPGLARLHEGEAGRRRLHDSCAAVStopRVGPYRVQPDRRLARRRRV
PDRDGREPPRLGGFRPRYQRQRLRQStopRRPGDGAGGRPIGLPADQAPPVRLVGRGGAGPGRLP
VLRQLAGQRRARQDQRVPELRHDRLPEPGLLRLRRRPDDREDLQGLLLRDRHLHGDRDRGRRTLR
PRTLQERGSPGRRPVQRRRLPQDLRAGGQVGRHCRPALRPLLPLQLRHHGQHRStopHGPGPSto
pQRRHRIRRLGAVADRGPASPPPPRY 
Figure 3-16:  Translation of Sequence DNA from Colony 5. 
 
  
SSGRSPTMetMRIKRTSNRSNAARRVRTTAVLAGLAAVAALTAPTPAAAAAPDIPIANVKAHLRQ
LESIATANGGNRAHGRAGYRASLDYMKAKLDAAGFTTRVQQFSASGRTGYNLTADWPGGDASQIV
MAGSHLDSVASGPGINDNGSGSSAVLETALAVARSGYQPTKHLRFAWWGAEELGLVGSRYYVNSL
GSAERAKISGYLNFDMIGSPNPGYFVYDDDPTIEKTFKDYFSGIGISTEIETEGDGRSDHAPFKN
AGVPVGGLFSGADYRKTSAQAAKWGGTVGQPFDRCYHSSCDTTANIDDTALDRNSDAIAYAVWEL
SQIEGRHHHHHHGT 
Figure 3-17:  Translation of Sequence DNA from Colony 5 with 
extraneous G deleted. 
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Con--------MRIKRTSNRSNAARRVRTTAVLAGLAAVAALTAPTPAAAAAPDIPIANVKAH  
5  SSGRSPTMMRIKRTSNRSNAARRVRTTAVLAGLAAVAALTAPTPAAAAAPDIPIANVKAH  
           **************************************************** 
ConLRQLESIATANGGNRAHGRAGYRASLDYMKAKLDAAGFTTRVQQFSASGRTGYNLTADWP  
5  LRQLESIATANGGNRAHGRAGYRASLDYMKAKLDAAGFTTRVQQFSASGRTGYNLTADWP  
   ************************************************************ 
ConGGDASQIVMAGSHLDSVASGPGINDNGSGSSAVLETALAVARSGYQPTKHLRFAWWGAEE  
5  GGDASQIVMAGSHLDSVASGPGINDNGSGSSAVLETALAVARSGYQPTKHLRFAWWGAEE  
   ************************************************************ 
ConLGLVGSRYYVNSLGSAERAKISGYLNFDMIGSPNPGYFVYDDDPTIEKTFKDYFSGIGIS  
5  LGLVGSRYYVNSLGSAERAKISGYLNFDMIGSPNPGYFVYDDDPTIEKTFKDYFSGIGIS  
   ************************************************************ 
ConTEIETEGDGRSDHAPFKNAGVPVGGLFSGADYRKTSAQAAKWGGTVGQPFDRCYHSSCDT  
5  TEIETEGDGRSDHAPFKNAGVPVGGLFSGADYRKTSAQAAKWGGTVGQPFDRCYHSSCDT  
   ************************************************************ 
ConTANIDDTALDRNSDAIAYAVWELSQIEGRHHHHHH--  
5  TANIDDTALDRNSDAIAYAVWELSQIEGRHHHHHHGT  
   ***********************************   
Figure 3-18:  Alignment results of modified Colony 5 sequencing DNA 
to the construct rScAP.  Alignment is 100% accurate, excess amino acids 
are the translation of vector sequences. 
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Chapter IV:   CONCLUSION TO SGAP  
 
 Like countless biochemists and biologists before, the complex and 
still unknown mechanisms of protein folding have caused infinite frustration 
and near psychosis for all involved.  Given the previous success of Ni et al.52 
in expressing the recombinant SgAP in a similar expression system to the 
native SgAP there is hope that using S. lividans as an expression system for 
ScAP will prove fruitful.  At present a plasmid that can easily be modified 
(deleting the superfluous G nucleotide) is available.  Furthermore, by 
following the roadmap set forth by Ni et al.52 acquiring the first unmutated 
recombinant ScAP should be merely a matter of time.  Considering the 
simplicity of doing site directed mutagenesis the mutants should follow 
quickly.  The only foreseeable difficulty could be the time to learn and adjust 
the laboratory accordingly to using a new bacterium (S. lividans) including 
learning the new techniques for transformation and expression.  Isolating the 
protein after expression should prove simple as S. lividans will secrete rScAP 
into the growth medium and the presence of the engineered His-tag on rScAP 
will facilitate easy purification. 
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Chapter V:  INTRODUCTION TO HISTATIN-5 N-TERMINUS  
5.1 Antimicrobial Peptides (AMPs) 
One of the most interesting class of peptides are the antimicrobial 
peptides (AMP), owing to their broad spectra of microbicidal functionality.  
Alternatively, they are known as cationic host defense peptides.55  In addition 
to the antimicrobial activity, AMPs have various essential functions in the 
host’s innate immunity.  Thus, the latter name better describes its overall 
function.   
AMPs can be ubiquitously found in nature, ranging from plants to 
humans.55  The exact classification for AMPs is broad; in general, the length 
of the peptide ranges anywhere from 12 to 50 amino acids, with 2–9 
positvely charged residues and at most 50% hydrophobic residues.55  
Furthermore, they are commonly thought to have similar three dimensional 
structures due to the similarities of their compositions.  In hydrophobic 
environments, such as that of the plasma membrane, they generally have β-
sheet or α-helix conformations.  Both secondary structures are well suited for 
membrane spanning roles, which is a common antimicrobial mechanism 
among AMPs and is necessary for many of them to function successfully as 
antimicrobials.56-58  The amphipathic nature of these peptides enables 
insertion into the membrane, which leads to pore formation.  This, in turn, 
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disrupts the integrity of the cell membrane, leading to cell lysis and loss of 
metabolites to the extracellular environment.59-62  It is interesting that AMPs 
are selectively active toward the foreign but not host cell; this feat is 
accomplished by the slight difference in the composition of celluar 
membranes.  The bacterial membranes are more negatively charged on the 
surface, thus enabling the positively charged AMPs to interact quite strongly.  
However, this is not how all AMPs work.  They have also been proposed to 
play major roles in the host’s innate and adaptive immunity,63-66 including 
lysing of tumor cells,67 preventing excitotoxicity caused by 
lipopolysaccharide(LPS),68 and acting as chemical markers during anti-
inflammatory responses and angiogenesis.68  Furthermore, some AMPs 
function in a fashion similar to normal antibiotics; they bind to the microbial 
enzyme or protein and inhibit its function.  Examples include attacins, which 
block the transcription of omp gene in E. coli,69 Buforin II, which binds DNA 
and RNA,70 or pyrrhocoricin, which binds and inactivates the chaperone 
DnaK.71   
It seems only natural that AMPs have generated a storm of commercial 
interests.  The potential for possible therapy, combined with the alarming 
decrease in efficacy for current generation of antibiotics have brought money 
and enthusiasm to this search.  Unfortunately, only few AMPs have made 
significant progress, in part to the need for high doses and the low 
therapeutic index, making them unacceptably dangerous for medicinal use.72  
Nonetheless, a couple of successful AMPs have been brought to the market.  
These have a common feature in that they are topical, enabling them to have 
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a high local but low systemic concentration.73  Further research may lead to a 
better understanding both its toxicity to humans and interaction with 
microbial targets, which could lead to more pharmaceutical and commercial 
interests. 
5.2 Histatin-5 
Histatins (Hs) are found in the saliva of higher primates and named 
due to their histidine rich character.74-75  The wide range of microbicidal 
activity of Hs includes one of the most prevalent fungi, Candida albicans,76-78 
and several families of bacteria.79  Interestingly, only two separate genes are 
responsible for the expression of histatins.  These genes, HTN1 and HTN2, 
encode the primary sequence for histatin-1 and histatin-3, respectively.80  
The remaining Hs variants (up to 50) found in the whole saliva are the 
products of post translational modification, namely proteolytic cleavage, of 
either Hs-1 or Hs-3.81  Histatin-5, for example, consists of the first 24 amino 
acid residues of Hs-3 (DSHAKRHHGY10 KRKFHEKHHS20 HRGY).81   
One interesting aspect of Histatin-5 is that while it is clearly 
antimicrobial, its exact mechanism remains under debate.  There are three 
schools of thought currently on this subject.  The first being proposed by 
Edgerton et al.82-85 is that the histatin-5 induces the non-lytic loss of ATP, 
which then binds to purinergic-like receptors which initiate apoptosis.  In this 
mechanism, the peptide interacts with the heat shock proteins (Ssa1/2) of  
C. albicans and is internalized.  Once inside the cell it binds to the potassium 
transporter (TRK1) which leads to the loss of cellular integrity, and cellular 
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death.82-85  The second proposed mechanism by Oppenheim et al.64-65 
involves the breakdown of the yeast’s respiratory machinery.  In this 
mechanism the peptide is internalized due to the electrochemical gradient 
(the inside of the cell being negative and histatin-5 being very positive).  
Once inside, it migrates to the mitochondria and is again internalized via a 
similar mechanism.  Histatin-5 is able to disrupt the electron transfer process 
of the mitochondria which leads to the accumulation of reactive oxygen 
species, oxidative stress and finally cellular death.86-87 
A third mechanism has more recently been proposed by Mochon et 
al.88 which contradicts both Oppenheim64-65 and Edgerton82-85 by saying that 
Histatin-5 does indeed cause a lytic event, although is unconventional in how 
it does that.  In this mechanism physiological levels of Histatin-5 were shown 
to create a single breach in the membrane allowing the rapid loss of ATP and 
K+.  This single breach site is the result of the fact that Histatin-5 acts this 
way only because of the membrane potential.  Upon creation of one lytic site, 
the membrane potential is lost and therefore a second lytic site is not 
possible.88   
Amino acid residues such as histidine, serine, tyrosine, and acidic 
aspartate and glutamate are well known to participate in metal binding.89  
The primary sequence of Hs 5 consists of seven histidines, two serines, two 
tyrosines, one glutamate, and one aspartate, creating multiple potential 
metal-binding sites.81  The presence of multiple metal-binding sites has been 
confirmed by a number of studies using calorimetric, and spectroscopic 
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techniques.  According to previous studies, there are three common metal-
binding motifs, which are the zinc-binding HEXXH13 the copper binding 
HXXXH,90 and the copper- and nickel-binding motif ATCUN (Amino Terminal 
CuII and NiII Binding) consisting of DSH.91   
Gusman et al.92 used spectrophotometric competition assays to 
determine whether Hs-5 binds both CuII and/or ZnII.  This study showed that 
free murexide, a metallochrome, in solution absorbs maximally at 520 nm, 
and upon addition of CuII or ZnII, the peak shifts to 500 nm, indicating the 
metal-murexide complex formation.  Addition of Hs-5 to this solution shifted 
the absorption maximum back to 520 nm, which clearly indicates the 
removal of metal ion from the original complex by the peptide to give free 
murexide.  The absorption at 520 nm due to free murexide was further 
confirmed by using EDTA, a good metal chelator, in place of the Hs-5 
peptide.92   
Melino et al.93 used UV-vis spectroscopy to show the similarities 
between Histatin-5 N-terminus metal binding and that of the ATCUN region 
of human serum albumin.  In this study, the disruption of the ATCUN site by 
substituting His-3 into Ala-3 drastically changed the UV-Vis spectrum.93  The 
major flaw of both these studies is that it did not go far enough into 
investigating to what stoichiometric ratios does metal bind.  Given the 
bountiful nature of Hs-5’s primary structure with regard to its possible metal-
binding ligands, it seems obvious that this peptide can bind more than one 
metal ion.  Nonetheless, these studies overlooked or discounted such 
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possibility.  Brewer and Lajoie94 investigated the potentials of Hs-5 in 
complexing with more than one metal ion using electrospray ionization mass 
spectrometry (ESI-MS).  The mass difference between one versus multiple 
metal ion bound complexes can be determined using ESI-MS.  In addition, 
the study clearly showed that Hs-5 has different affinities for different metal 
ions under different conditions.  For instance, with 5:1 metal-to–peptide 
stoichiometric ratio in solution three CuII ions were bound to Histatin-5 (but 
no FeII).94  With a change in the pH from 6.5 to 7.0 another CuII ion is 
bound.94   The ratio of metal to peptide used in preparation greatly affects 
the number of bound metals.94  For instance when prepared with a 2:1 CuII 
to peptide ratio only one CuII ion is bound, whereas at a 10:1 ratio four CuII 
ions are bound.94  Again, this study is limited to only the metal-binding ability 
of Hs-5 and does not provide mechanistic information toward its in vivo 
antimicrobial activity. 
The above potential mechanisms, particularly the ones proposed by 
Mochon et al.88 and Edgerton et al.,82-85 provide an interesting situation that 
arises when one takes in to account the metal binding characteristics of 
Histatin-5.  Both Mochon and Edgerton emphasize the importance of the 
positive charge on Histatin-5.  For one, the positive charge is necessary for 
the peptide to interact with the negatively charged outer leaflet of the plasma 
membrane.  Second, the positive charge provides a necessary function in 
making entrance into the cell favorable based on the net negative charge 
inside the cell.  Changing Lys-13 to Glu and Arg-22 to Gly decreased 
candidacidal activity significantly.95  It was later shown that these changes 
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effect the entrance into the cell and this could be the cause of the decreased 
candidacidal activity.88  The overall charge of the peptide is certainly 
important for its function as an AMP.  Would metal binding affect this activity 
by neutralizing the apparent charges?  If so, what metal binding species is 
present in the human salivary environment?  Further, would this species lack 
sufficient charge to attack C. albicans as Edgerton and Mochon proposed?  In 
consideration of the metal-binding ability of Hs-5 it is essential to determine 
the possible role of CuII in the in vivo antimicrobial activity of Hs-5.  In fact, a 
previous study suggested a possible involvement of metal, particularly Zn, in 
the interaction of Hs-5 and cellular membranes.  The study showed that Hs-5 
can selectively fuse the negatively charged small unilamellar vesicles in the 
presence of Zn.96 
In order to investigate how the binding of metals affects the 
catecholase properties of Hs-5, Tay97 used UV-vis spectroscopy to monitor 
catechol oxidation (using 3-methyl-2-benzothiazolinone hydrazone 
Hydrochloride as an indicator for o-quinone, the oxidative product of 
catechol) by Hs-5 upon addition of various ratios of CuII.  It was evident that 
there was no activity until greater than 1 equivalent of CuII was added and a 
steady increase in activity was observed until approximately 8 equivalents of 
CuII were added.97  In context of the ESI-MS study,94 it seems unlikely that 
all 8 equivalents of CuII were bound to the peptide, but rather that maximal 
activity should fall somewhere between 3 and 4 CuII ions bound.  This study 
was further refined using the 4,5-di-chloro-catechol (DCC) as the substrate.  
The benefit of using DCC is that catalytic turnover of DCC is approximately 
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200-fold smaller than that of catechol.  As such, any metal-ligand-substrate 
complex that forms should exist long enough to be observed using optical 
UV-Vis spectroscopy; whereas catechol would form complex and react too 
quickly to be well observed.  The result of this experiment revealed a 3:1 
DCC:CuII4-Hs-5 ratio.  This infers that three metal centers exist in the peptide 
each of which can bind DCC.  Tay97 was further able to assign metal binding 
sites using CoII titration as monitored by NMR.  However, in this experiment 
only two metal sites were assigned, the first being the HEXXH ZnII binding 
motif (or for that matter the HXXXH CuII-binding site) and the second being 
the DSH ATCUN site.  The third site was not apparent using NMR with up to 6 
equivalents of CoII.  This of course, based on the ESI-MS study by Brewer 
and Lajoie,94 may be a result of the rather large differences that may arise 
with a variation in metals used.  At a 4:1 metal-to-peptide ratio using CuII we 
may see three metals bind, but with CoII perhaps only two may bind.  Further 
titration of CoII may have revealed the third binding site. 
These questions however are outside of the scope of this current 
study.  The primary interest is not in its ability to kill C. albicans but rather in 
its ability to utilize metal to perform oxidative chemistry.  In recent years, 
there has been a great deal of interest in the study of peptides that have the 
ability to catalyze enzymatic reactions.  The idea is that these peptides can 
be utilized as model systems to study the mechanisms for the more complex 
proteins.  The goal of my research is to reveal greater insight into copper ion 
chemistry using Histatin-5 as a natural system.  So, while there is obvious 
direct medical relevance in studying any AMP, the exact nature of this study 
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deals not with the medical significance of the subject, but rather with the 
Histatin-5’s other unique properties, namely oxidative chemistry under near 
physiological conditions in vitro.  In determining the oxidative properties of 
the full length Hs-5 three potential metal binding sites for CuII were 
observed.  Theoretically, by synthesizing the peptide in two separate 
fragments one might be able to better isolate the proposed metal binding 
sites.  From this better characterization of the metal binding sites, their 
affinities and oxidative properties may be determined.  
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Chapter VI: HISTATIN-5 N-TERMINUS MATERIALS AND 
METHODS 
 Histatin-5 and the N-terminal histatin-5 fragment (Hs-5N) were 
synthesized and purified and characterized at the University of South Florida 
Peptide Synthesis and Mass Spectroscopy Center.  The concentration was 
determined using A280 with ε=1440 M—1 cm—1.  Anhydrous copper sulfate 
and HEPES was purchased from Fisher Scientrific.  pyrocatechol (~99%) and 
3-methyl-2-benzothiazolinone hydrazone hydrochloride monohydrate (98%), 
MBTH, were acquired from Sigma–Aldrich Inc.  The o-quinone from catechol 
oxidation reacts with MBTH to form a colored adduct that with a maximum 
absorption at 500 nm (ε= 32500 M—1 cm—1).  All spectroscopic studies were 
conducted on a Cary-50 UV/Vis spectrometer unless stated otherwise. 
6.1 Metal Binding Studies 
Metal binding was monitored in two ways.  The first method was CuII 
titration while monitoring catechol oxidation at 500 nm.  In the second 
method the formation of CuII-Hs-5N complex was monitored directly over 
200-800 nm range.  Catechol oxidation experiments were conducted over a 
range of 0.0-5.0 equivalents of CuII with 1.0 mM catechol and equal molarity 
of the o-quinone-specific indicator (MBTH) in 100 mM HEPES at pH 7.0 with 
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1.01 μM Hs-5N.  Optical CuII titration was performed using a CuII range of 
0.0-20.0 equivalents with 100 μM Hs-5N in 100 mM HEPES at pH 7.0.   
6.2 Kinetics Studies 
Kinetics experiments were monitored at 500 nm from the red MBTH-o-
quinone adduct.  Catechol and MBTH were varied from 0.0 to 6.4 mM were 
incubated with 1.0 μM Cu2II-Hs-5N in 100 mM HEPES at pH 7.0.  The initial 
rate was determined from the slope of the change in absorbance versus time 
over a period of 0-5 minutes in the linear range.  Kinetic constants were 
determined using Sigma Plot 11 by fitting data to the appropriate equations.  
A mechanistic Job plot was constructed by continuously varying the mol 
fraction between the CuII-Hs5N complex and the substrate, while keeping the 
overall concentration constant.  Kinetic studies were also performed in the 
presence of hydrogen peroxide, H2O2.  In one experiment H2O2 was titrated 
over a range of 0.0 to 32.0 mM while holding constant the catechol, MBTH 
and CuII-Hs5N constant at 3.2 mM, 3.2 mM and 1.5 μM, respectively.  For 
another series of experiments the peroxide concentration was held constant 
while varying the catechol and MBTH concentrations (between 0.0 to 6.0 mM 
catechol/MBTH).  The oxidation of catechol was determined in the presence 
of several concentrations of H2O2 ranging 0.0-32.0 mM.   
6.3 DCC Binding Studies 
4,5-di-chloro-catechol, DCC, was used to study the substrate binding 
due to its significantly smaller reactivity compared to catechol, in order to 
monitor the interaction between this substrate and the Cu2II-Hs-5N complex.  
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DCC was dissolved in DMSO due to its low solubility in water or buffer.  Up to 
3 equivalents of DCC was titrated into Cu2II-Hs-5N complex.  The binding was 
monitored over the 200-800 nm.   An optical Job plot was also attained as 
described above. 
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Chapter VII: HISTATIN-5 N-TERMINUS RESULTS AND  
DISCUSSION 
Metal binding to the full length Histatin-5 (Hs-5) was investigated 
previously and was able to concretely determine two metal binding sites, the 
ATCUN region as well as the copper ion binding domain (HXXXH).97  In the 
same study Tay determined that each histatin-5 peptide can bind more than 
2 metal ions.97  In analyzing the metal binding to Hs5N the goal was to 
determine the stoichiometry of metal binding to the Hs5N fragment using 
both optical studies as well as kinetics to determine the redox active species. 
Upon addition of CuII to the Hs5N solution a peak at approximately 525 nm 
appears.  Subsequent addition of CuII increased the intensity of the 525 nm 
peak until 2.0 equivalents of CuII.  Further addition of CuII shifted the peak 
towards the longer wavelengths.  This shift is caused by the CuII filling the 
second binding site (absorbance around 600nm).  This data is displayed in 
Figure 7-1.  The absorption at 525 (A525) versus concentration of CuII is 
shown in Figure 7-2.  From Figures 7-1 and 7-2 two valuable pieces of 
information are acquired.  First, that the N-terminal region of Histatin-5 has 
two CuII binding sites.  Second, the dissociation constant, Kd, for CuII binding 
Hn5N is 6.37 x 10—5 M.  The absorbtion maximum at 525 nm is indicative of 
a copper center with square planar geometry.98   
 Cu Binding Optical Titration
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Figure 7-1:  Optical titration of CuII binding to Hs5N. Optical titration of 
CuII with 100 μM Hn5N in 100 mM HEPES pH 7 and 25 °C, which displays 
main peak at 525 nm, with shift towards 800 nm after 2 equivalents of 
copper ion(relative to Hs-5N).  The shift towards 800 nm is likely the result 
of increased absorption by the free CuII ion in solution.  Each spectra 
represents a 0.2 equivalents of CuII from 0-2 equivalents followed by 0.4 
equivalents from 2-4.4 equivalents. 
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Figure 7-2:  CuII binding to Hs5N.  Titration of CuII showing saturation of 
the A525 binding site when ratio CuII to Hs-5N is 2:1.  100 μM Hn5N, 100 
mM HEPES pH7 and 25.0 °C.  The A525 was fit to a quadratic equation, thus 
1:1 binding with a KD of 6.37 x 10—5 M. 
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While the ability of Hs-5N to bind copper is important, more important 
is how this copper activates Hs-5N to promote oxidative catalysis.  There was 
no increase in activity over the uncatalyzed reaction until greater than one 
equivalent of copper was added.  Considering the flexible stretch of peptide 
between the two potential metal binding sites it is possible that with one 
copper bound the peptide might fold over the copper ion in such a way as to 
prevent the substrate from binding.  It is further possible that one CuII center 
is simply insufficient for catecholase activity; catecholase activity requires a 
two electron transfer and therefore a single CuII to CuI (single electron 
transfer) is not enough as seen with tyrosinase.  This is a similar 
phenomenon that Tay observed.97   
The rate at various concentrations of catechol and MBTH while keeping 
the Cu2II-Hs-5N complex concentration constant (at 1.0 μM) in 100 mM 
HEPES pH 7.0 at 25 °C (Figure 7-4) was tested.  This study showed 
increased catalytic rate until saturation at higher levels of substrate.  The 
data displays Michaelis-Menten like steady state kinetics and thus can be well 
fitted to the Michaelis-Menten equation: 
[ ]
[ ]CAK
CAV
NHs
Max
+= 50
ν  
Where Vo  is the observed rate, Vmax is the maximum rate, KHs5N is the 
Michaelis-Menten constant, and [CA] is the concentration of substrate, in this 
case catechol.  This is based upon the assumption that substrate 
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Figure 7-3:  Activity profile for catechol oxidation with CuII titration. 
Equivalents of CuII titrated into 1 μM Hn5N with 1 mM Catechol/MBTH in 100 
mM HEPES pH 7.0 and 25 °C. 
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concentration is much greater than the complex concentration, i.e. 
[catechol]>>[Hs5N- CuII].  Further assumed is that the reaction proceeds 
thusly:  
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[Cu(II)-Hn5-CA][Cu(II)-Hn5] + [CA] [Cu(II)-Hn5] + o-quinone
k1
k-1
kcat
 
Based upon the data in Figure 7-4, it is possible to determine the KHs5N 
to be 3.2 x 10—3 M, the kcat to be 2.20 x 10—2 s—1, and the second order rate 
constant (kcat/KM) to be 6.88 M—1 s—1.  This represents a 4.6 x 104 rate 
enhancement over the autooxidation of catechol (4.74 x 10—7 s—1). 
In an effort to better understand the interaction between the metal-
peptide complex and the substrate, the slow reacting substrate, DCC, was 
utilized in an optical study (Figure 7-5).  During this study, DCC was titrated 
into the 1.0 mL cuvette that contained 100 μM Complex (2:1) in 100 mM 
HEPES pH 7.  Upon addition of DCC to the 2:1 complex two new absorption 
peaks appears at 306 nm and 426 nm both of which saturate at a 1:1 ratio 
DCC to complex.  It appears that the Cu2II-Hs-5N complex can bind a single 
equivalent of DCC.  This finding can be further supported by Figure 7-6 in 
which a Job plot is shown. 
The Job plot in Figure 7-6 supports the one to one substrate binding 
first proposed by the optical DCC titration study shown in Figure 7-5.  It 
makes sense that the Cu2II-Hs-5N complex can bind just a single substrate 
makes sense considering the proposed mechanism of catechol oxidation.  
Since catechol oxidation to o-quinone requires a two-electron transfer, of 
which each CuII may contribute one (becoming CuI), and Hs-5N can bind two 
copper ions, it seems primed particularly for a single substrate reaction.   
Finally, the effect of hydrogen peroxide on the Cu2II-Hs-5N system was 
explored.  Previous studies have shown that hydrogen peroxide acts as a 
second substrate,97 and increases the rate of catechol to o-quinone.  Similar 
studies were carried out to determine if this second substrate interacts with 
the metal center on the N-terminus of Histatin-5.  First, an experiment with 
increasing concentration of H2O2 (0-32 mM) while holding the concentration 
of the 2:1 complex and Catechol/MBTH constant at 1.5 μM and 3.2 mM, 
respectively.  This demonstrated that saturation of hydrogen peroxide was 
possible and thereby implying Michaelis-Menten like steady-state kinetics 
(Figure 7-7).  The data were fit to the modified Michaelis-Menten equation to 
determine the relevant constants: 
[ ]
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The KH2O2 is 5.4 x 10—3 M, a value 1.7 times higher than the KHs5N for 
catechol, therefore displaying slightly weaker affinity for hydrogen peroxide 
(or a higher kcat).  The kcat for H2O2 catalyzed reaction is 4.5 x 10—2 s—1, thus 
giving a second order rate constant (kcat/KM) of 8.3 s—1 M—1, an enhancement 
of 2.0 and 1.2, respectively, compared to catechol oxidation by Hs-5N 
without H2O2. 
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Figure 7-4:    Graph of increasing catalytic rate with increasing 
substrate concentration until saturation.  1.0 μM Cu2II-Hs-5N complex  
in 100 mM HEPES pH 8.0 25 °C.  The data is fitted to a the Michaelis-Menten 
equation in order to determine rate constants KM, kcat, and kcat/KM. 
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Figure 7-5:  DCC Binding by Optical Spectroscopy.  Optical of DCC 
binding studied with 100 μM Cu2II-Hs-5N complex in mixture HEPES and 
DMSO (in order to keep DCC soluble).  Saturation appears slightly over 1 
equivalent DCC.  DCC binding was fit to a quadratic equation giving a 
dissociation constant of 16 μM.   
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Figure 7-6:   Optical Job Plot.  Job plot based on change of absorbance at 
306 nm as the mol fraction of His5N is varied.  Experimental conditions: 0-
200 μM Hs5N (0-400 μM CuII, i.e. 2:1 complex), 0-200 μM DCC, 100 mM 
HEPES pH 7.0 and 25 °C. 
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Figure 7-7:  Influence of hydrogen peroxide on catechol oxidation.  
Catechol oxidation by Cu2II-Hs-5N complex in the presence of varied amounts 
of hydrogen peroxide in 100 mM HEPES pH 7.  Data display Michaelis-Menten 
like kinetics and so is fit to the modified Michaelis-Menten equation, from 
which relevant constants KM, kcat, and kcat/KM can be obtained. 
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 To better elucidate the manner in which the two substrates, hydrogen 
peroxide and catechol, influence the binding of the other to the active site,  
varying concentrations of catechol were incubated with 1.5 μM Cu2II-Hs-5N  
complex with varying concentrations of hydrogen peroxide.  This study 
provided multiple graphs that showed Michaelis-Menten-like kinetics as a 
function of either [Catechol] or [H2O2] (as shown in Figure 7-8).  
Furthermore, a second graph can be attained from the same data, that is a .  
The basic Michaelis-Menten equation, as stated above, can be replotted in a 
linear relationship in accordance with the Hanes-Woolf plot: 
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From which two secondary plots may be attained, one which relates the y-
intersect of all the lines on Figure 7-9 part A to the inverse of the catechol 
concentration (Figure 7-9 part B) and another which relates the slopes of the 
same lines to the inverse of the catechol concentration (Figure 7-9 part C).  
From combining data represented on these graphs the various affinity 
constants may be ascertained, which are depicted in Table 1, as well as a 
comparison to the affinity constants in previous studies.99 
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Figure 7-8:  Catechol oxidation by various concentrations of catechol 
and various concentrations of hydrogen peroxide.  1.5 μM complex 
(2:1) with varying amounts of catechol (0-6.0 mM) and hydrogen peroxide 
(0-32 mM) in 100 mM HEPES pH 8.0.  The graph clearly shows saturation of 
hydrogen peroxide above 16mM.  From this data the Hanes-Woolf plot shown 
in Figure 6-9 is accomplished. 
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Figure 7-9:  Hanes-Woolf Analysis.  Hanes analysis of the oxidation of 
catechol by Cu2II-Hs-5N complex in the presence of varied amounts of 
hydrogen peroxide based upon data presented in Figure 7-8.  The smaller 
submissive plots below are a replot of the various data represented in the 
larger dominatrix plot above.  From which the values in Table 1 were 
gathered.   
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There are a few interesting things to note based on the data presented 
in Table 1.  First, the kcat for the catechol oxidation reaction with H2O2 shows 
a 1.97 x 105 fold enhancement versus the autooxidation reaction.  Second, 
the apparent KH2O2 is 33 % higher than the intrinsic KH2O2 while the apparent 
Kcatechol is nearly unchanged than the intrinsic Kcatechol.  This indicates that the 
binding of H2O2 has no effect on the binding of catechol, while the binding of 
catechol slightly inhibits or blocks the binding of H2O2.  Third, in essence this 
is similar to the results previously shown99 for the full length peptide, the 
only difference is the degree to which the apparent KH2O2 is lowered relative 
to the intrinsic value.  This indicates that the catalytically relevant region of 
the peptide, in so much as the activity in which we are measuring, may 
largely take place in the N-terminus, and not in the C-terminus. 
 
 
 
 
 
 
99 
 
100 
 
Constant Histatin-5 N terminus Histatin-5 Full length97 
kcat with H2O2 9.33 x 10—2 s—1  Not reported 
Apparent KH2O2 4.21 x 10—3 M 5.23 × 10—3 M 
Intrinsic KH2O2 3.16 x 10—3 M 2.26 x 10—3 M 
Apparent KCatechol 3.42 x 10—3 M 3.63 x 10—3 M 
Intrinsic KCatechol 3.55 x 10—3 M 3.06 x 10—3 M 
Table 7-1:  Comparison of Hs-5N to full length Hs-5.  The valuable affinity 
constants and catalytic rate constants ascertained from the Hanes-Woolf Plot 
compared to the ones collected by Dr. William Tay for the full length 
peptide.97 
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Chapter IIX: HISTATIN-5 N-TERMINUS CONCLUSION 
This study focused essentially on reducing the metal binding sites in 
the Histatin-5 peptide system which is well known for antimicrobial activity, 
candidacidal and bactericidal.  The aim of this was to determine whether the 
amino terminus of Hs-5 showed the oxidative activity of the full length 
peptide.  In many ways, it mirrored the study done by Dr. Tay,97 but the goal 
was to determine what truly is active in histatin-5.  As was discussed earlier, 
the primary sequence of histatin-5 shows many sites which might bind metal 
and therefore be vital for the oxidation activity displayed by histatin-5.  
Bisecting the sequence effectively halves the metal binding sites to two sites, 
the ATCUN region and the HHGY sequence (the most likely candidate 
knowing that Hs5N binds two metals, one of which we know is the ATCUN 
region).  From the data presented, there can be no doubt that the N-
terminus has the ability to bind CuII, a redox-active metal, and the substrate 
(catechol), but furthermore shows similar affinity constants, as well as kinetic 
parameters (kcat and kcat/KM) and peroxide influences (Table 7-1) of the full 
length peptide.  With this in mind, it is reasonable to say that the N-terminus 
is responsible for the oxidative activity seen in the full length peptide.  It is 
impressive to see such a small and simple system that is able to perform 
such complex chemistry attaining a 1.97 x 105-fold rate enhancement. 
 
102 
 
 
   
Chapter IX: References 
 [1]  Fry, S.C. (1988). The Growing Plant Cell Wall: Chemical and Metabolic  
Analysis. (Harlow, UK: Longman). 
[2]  J. Blackwell and M.A. Weih.  (1980)  Structure of chitin-protein  
complexes: Ovipositor of the ichneumon fly Megarhyssa.   J. 
Mol. Biol. 137:49–60 
[3]  Taylor, A.  (1993)  Aminopeptidases: structure and function.  FASEB J.   
7: 290-298  
[4]  Taylor, A.  (1993)  Aminopeptidases: Towards the mechanism of   
action.  Trends  Biochem. Sci.  18:167-172 
[5]  Gonzales, T.;  Robert-Baudory, J.;  (1996)  Bacterial aminopeptidases:  
properties and functions.  FEMS Microbiol Rev.  18: 319-344 
[6]  Brown, R.S.;  Bennet, A.J.;  Slebocka-Tilk, H.  (1992)  Recent  
Perspectives Concerning the Mechanism of H3O+ and OH_  
Promoted Amide Hydrolysis.  Acc. Chem. Res.  25: 481-488 
[7]  Cledland, W. W.; Henngge, A.C.;  (1995)  Mechanisms of phosphoryl  
and acyl transferase.  FASEB J.  9: 1585-1594 
[8]  Cox, Robin.  (2005)  A comparision of the mechanisms of hydrolysis of  
benzimidates, esters, and amides in sulfuric acid media.  Can. J.  
Chem.  83:  1391-1399 
 
103 
 
[9]  Voet, D.;  Voet, J.  (2003)  Biochemistry:  Biomolecules, Mechanism of  
Enzyme Action, and Metabolism.  3rd Edition. Volume 1.  John 
Wiley and Sons.  New Jersey  ISBN: 0-471-25090-2 
[10]  Storer, A.C.;  Ménard, R.  (1994)  Catalytic mechanism in papain  
family of cysteine peptidases.  Methods of Enzymology.  244: 
486-500 
[11]  Sturrock, E.D.;  Natesh, R.;  van Rooyen, J.M.;  Archarya, K.R.;   
(2004)  Structure of angiotensin-1-converting enzyme.  Cell. 
Mol. Life Sci.  61: 2677-2686 
[12]  Riordan, James F.  (2003)  Angiotensin-1-converting enzyme and its  
relatives.  Gen. Biol.  4: 225 
[13]  Matthews, Brian W.  (1988)  Structural Basis of the Action of  
Thermolysin and Related Zinc Peptidases.  Acc. Chem. Res.  21: 
333-340 
[14]  Gordon, K.;  Redelinghuys, P.;  Schwager, S.L.;  Ehlers, M.R.;   
Papageorgiou, A.C.;  Natesh, R. et al.  (2003)  Deglycosylation,  
processing, and crystallization of human testis angiotensin- 
converting enzyme.  Biochem. J.  371: 437-442 
[15]  Taunton, J.  (1997)  How to starve a tumor.  Chem. Biol. 4: 493 
[16]  Griffith, E.C.;  Su, Z.;  Turk, B.E.;  Chen, S.;  Chang, Y.-H.;  Wu, Z.;   
Biemann, K.;  Liu, J.O.  (1997)  Methionine aminopeptidase 
(type 2) is the common target for angiogenesis inhibitors AGM-
1470 and ovalicin.  Chem. Biol. 4: 461 
 
104 
 
[17]  Sin, N.;  Meng, L.;  Wang, M.Q.;  Wen, J.J.;  Bornmann, W.G.;  Crews,  
C.M.  (1997)  The anti-angiogenic agent fumagillin covalently 
binds and inhibits the methionine aminopeptidase, MetAP-2.  
Proc. Natl. Acad. Sci. USA.  94: 6099 
[18]  Lowther, W.T.;  McMillen, D.A.;  Orville, A.M.;  Matthews, B.T.  (1998)   
The anti-angiogenic agent fumagillin covalently modifies a 
conserved active-site histidine in the Escherichia coli methionine 
aminopeptidase.  Proc.Natl. Acad. Sci. USA.  95: 12153 
[19]  Liu, S.;  Widom, J.;  Kemp, C.W.;  Crews, C.M.;  Clardy, J.  (1998)   
Structure of Human Methionine Aminopeptidase-2 Complexed 
with Fumagillin.  Science 282: 1324-1327 
[20]  Pulido-Cejudo, G.;  Conway, B.;  Proulx, P.;  Brown, R.;  Izaguirre,  
C.A.  (1997)  Bestatin-mediated inhibition of leucine 
aminopeptidase may hinder HIV infection.  Antiviral Res.  36: 
167 
[21]  Holz, Richard C. (2002)  The aminopeptidase from Aeromonas  
proteolytica: structure and mechanism of co-catalytic metal 
centers involved in peptide hydrolysis.  Coord. Chem. Rev.  232: 
5-26 
[22]  Bayliss, M.E.;  Prescott, J.M.  (1986)  Modified activity of Aeromonas  
aminopeptidase: metal ion substitutions and role of substrates.  
Biochemistry 25: 8113-8117 
 
 
105 
 
[23]  Spungin, A.;  Blumber, S.  (1989)  Streptomyces griseus  
aminopeptidase is a calcium-activated zinc metalloprotein: 
Purification and properties of the enzyme.  Eur. J. Biochem.  
183: 471-477 
[24]  Ben-Meir, D.;  Spungin, A.;  Ashkenazi, R.;  Blumberg, S.;  (1993)   
Specificity of Streptomyces griseus aminopeptidase and 
modulation of activity by divalent metal ion binding and 
substitution.  Eur. J. Biochem.  212: 107-112 
[25]  Lin, L.-Y.;  Park, H.I.;  Ming, L.-J.  (1997)  Metal binding and acitve  
site structure of di-zinc Streptomyces griseus aminopeptidase.  
J. Biol. Inorg. Chem.  2: 744-749 
[26]  Harris, M.N.;  Ming, L.-J.  (1999)  Different phosphate binding modes  
of Streptomyces griseus aminopeptidase between crystal and 
solution states and the status of the zinc-bound water.  FEBS 
Letters.  455: 321-324 
[27]  Greenblatt, H.M.;  Almog, O.;  Maras, B.;  Spungin-Bialik, A.;  Barra,  
D.;  Blumberg, S.;  Shoham, G.  (1997)  Streptomyces griseus 
aminopeptidase: X-ray crystallographic structure at 1.75 Å 
resolution.  J. Mol. Biol. 265: 620-636 
[28]  Kelly, J.S.;  Dardinger, D.E.;  Butler, L.G. (1975)  Hydrolysis of  
phosphonate esters catalyzed by 5’-nucleotide 
phosphodiesterase.  Biochemistry.  14: 4983-4988 
 
 
106 
 
[29]  Bornscheur, U.T.;  Kazlauskas, R.J.  (2004)  Catalytic Promiscuity in  
Biocatalysis:  Using Old Enzymes to Form New Bonds and Follow 
New Pathways.  Angew. Chem. Int. Ed.  43: 6032-6040 
[30]  Romsicki, Y.; Scapin, G.;  Beaulieu-Audy, V.;  Patel, S.;  Becker, W.;   
Kennedy, B.P.;  Asante-Appiah, E.  (2003)  Functional 
Characterization and Crystal Structure of the C215D Mutant of 
Protein-tyrosine Phosphatase-1B.  J.  Biol. Chem.  278: 29009-
29015 
[31]  Hancock, Robert EW.; Diamond, G. (2000)  The Role of cationic  
antimicrobial peptides in innate host defences.  Trends in 
Microbiology. 8:402-410 
[32]  Park, H.I.;  Ming, L.-J.  (1999)  A 1010 Rate Enhancement of  
Phosphodiester Hydrolysis by a Dinuclear Aminopeptidase—
Transition-State Analogues as Substrates?.  Angew. Chem. Int. 
Ed.  38: 2914-2916 
 [33]  da Silva, GFZ.; Ming, LJ.  (2005)  Catechol Oxidase Activity of Di-Cu2+  
Substituted Aminopeptidase from Streptomyces griseus.  J. 
Amer. Chem Soc Comm.  127: 16380-16381 
[34]  Schmidt, D.M.;  Mundorff, E.C.;  Dojika, M.;  Bermudez, E.;  Ness,  
J.E.;  Govindarajan, S.;  Babbit, P.C.;  Minshull, J.;  Gerlt, J.A.  
(2003)  Evolutionary Potential of (beta/alpha)8-barrels: 
functional promiscuity produced by single substitutions in the 
enolase superfamily.  Biochemistry.  42: 8387-8393   
 
107 
 
[35]  Khersonsky, O.;  Roodveldt, C.;  Tawfik, D.S.  (2006)  Enzyme  
Promiscuity: evolutionary and mechanistic aspects.  Curr. Opin. 
In Chem. Biol.  10: 498-508 
[36]  O’Loughlin, T.L.;  Patrick, W.M.;  Matsumura, I.  (2006)  Natural  
history as a predictor of protein evolvability.  Protein, 
Engineering, Design, and Selection.  19: 439-442 
[37]  Guo, H.H.;  Choe, J.;  Loeb, L.A.  (2004)  Protein tolerance to random  
amino acid change.  Proc. Natl. Acad. Sci. USA. 101: 9205-9210 
[38]  Rennell, D.;  Bouvier, S.E.;  Hardy, L.W.;  Poteete, A.R.  (1991)   
Systematic mutation of bacteriophage T4 lysozyme.  J. Mol. Biol.  
222: 67-88 
[39]  Axe, D.D.;  Foster, N.W.;  Fersht, A.R. (1998)  A Search for Single  
Substitutions that Eliminate Enzymatic Function in a Bacterial 
Ribonuclease.  Biochemistry  37: 7157-7166 
[40]  Malmström, B. G. (1982)   Enzymology of Oxygen.  Annu. Rev.  
Biochem.  51: 21-59. 
[41]  Gerdemann, C.;  Eicken, C.;  Krebs, B.  (2002)  The Crystal Structure  
of Catechol Oxidase:  New Insight into the Function of Type-3 
Copper Proteins.  Acc. Chem. Res.  35: 183-191  
[42]  Katoh, S.  (1960)  A New Copper Protein from Chlorella Ellipsoidea.   
Nature.  186: 533-534 
[43]  Neish, A. C.  (1939)  Chloroplasts. II. Their chemical composition and  
the distribution of certain metabolites between the chloroplasts 
and the remainder of the leaf.   Biochem. J., 33: 300-308 
108 
 
[44]  Green, L. F.; McCarthy, J. F.; and King, C. G.  (1939)  Inhibition of  
Respiration and Photosynthesis in Chlorella pyrenoidosa by 
Organic Compounds that Inhibit Copper Catalysis.   J. Biol. 
Chem., 123: 447 -453 
[45]  Gorman, D.S.;  Levine, R.P.  (1965)  Cytochrome F and Plastocyanin:  
Their Sequence in the Photosynthetic Electron Transport Chain 
of Chlamydomonas reinhardi.  Proc. Nat. Acad. Sci. 54: 1665-
1669 
[46]  Church, W.B.;  Guss, J.M.;  Potter, J.J.;  Freeman, H.C.  (1986)  The  
Crystal Structure of Mercury-substituted Poplar Plastocyanin at 
1.9À Resolution.  J. Biol. Chem.  261: 234-237 
[47]  Gray, H.B.;  Malmström, B.G.;  Williams, R.J.P.  (2000)  Copper  
coordination in blue proteins.  J. Biol. Inorg. Chem.  5: 551-559 
[48]  MacPherson, I.S.;  Murphy, M.E.P.  (2007)  Type-2 copper-containing  
enzymes.  Cell. And Mol. Life Sci.  64: 2887-2899 
[49]  Decker, H.;  Schweikardt, T.;  Tuczek, F.  (2006)  The First Crystal  
Structure of Tyrosinase:  All Questions Answered?  Angew. 
Chem. Int. Ed.  45: 4546-4550 
[50]  Pelmenschikov, V.;  Siegbahn, P.E.  (2005)  Copper-zinc superoxide       
dismutase:  Theoretical insights into the catalytic mechanism.  
Inorg. Chem.  44: 3311-3320 
 
 
 
109 
 
[51]  Matoba, Y.;  Kumagai, T.;  Yamamato, A.;  Yoshitsu, H.  (2006)  
Crystallographic Evidence That the Dinuclear Copper Center of 
Tyrosinase Is Flexible during Catalysis.  J. Biol. Chem.  281: 
8981-8991 
[52]  Ni, SX.;  Cossar, D.;  Man, A.;  Norek, K.;  Miller, D.;  Kearse, C.;   
Tsvetnitsky, V.  (2003)  Purification and characterization of 
recombinant Streptomyces griseus aminopeptidase.  Protein 
Expression and Purification.  30: 62-68 
[53]  Henderson, G.;  Krygsman, P.;  Liu, CJ.;  Davey, CC.;  Malek, LT.   
(1987)  Characterization and Structure of Genes for Proteases A 
and B from Streptomyces griseus.  J. of Bac.  169: 3778-3784 
[54]  Long, CM.;  Virolle, MJ,;  Chang, SY.;  Chang, S.;  Bibb, MJ.  (1987)   
α-Amylase Gene of Streptomyces limosus:  Nucleotide 
Sequence, Expression Motifs, and Amino Acid Sequence 
Homology to Mammalian and Invertebrate α-Amylases.  J. of 
Bac.  169: 5745-5754 
[55]  Brown, Kelly L.; Hancock, Robert EW. (2006) Cationic Host Defense  
(antimicrobial) Peptides.  Current Opinion in Immunology.  18: 
24-30 
[56]  Ganz, T. (1990) Defensins. Eur. J. Haematol.  44: 1–8 
[57]  Raj, P. A.; Marcus, E.; Sukumaran, D. K. (1998)  Structure of human  
salivary histatin 5 in aqueous and nonaqueous solutions. 
Biopolymers.  45: 51–67 
 
110 
 
[58]  Turner, J.; Cho, Y.; Dinh, N. N.; Waring, A. J.; Lehrer, R. I. (1998)   
Activities of LL–37, a cathelin-associated antimicrobial peptide 
of human neutrophils. Antimicrob. Agents Chemother. 42: 
2206–2214 
[59]  Zaiou, M. (2007)  Multifunctional antimicrobial peptides: therapeutic  
targets in several human diseases. J. Mol. Med.  85: 317–329 
[60]  Mor, A. (2006)  Peptides, antimicrobial. In editor(s); Ed. Kirk-Othmer  
Encyclopedia of Chemical Technology (5th Edition) 
[61]  Smet, K. D.; Contreras, R.  (2005) Human antimicrobial peptides:  
defensins, cathelicidins and histatins. Biotech. Letters.  27: 
1337–1347 
[62]  Kamysz, W.; Okrój, M.; Łukasiak, J. (2003)  Novel properties of 
antimicrobial peptides. Acta Biochimica Polonica.  50: 461–469 
[63]  Yang, D.;  Biragyn, A.;  Hoover, DM.;  Lubkowski, J.;  Oppenheim, JJ.   
(2004)  Mutliple roles of antimicrobial defensins, cathelicidins 
and eosinophil-derived neurotoxin in host defense.  Annu Rev 
Immunology.  22: 181-215 
[64]  Bowdish, DM.;  Davidson, DJ.;  Lau, YE.;  Lee, K.;  Scott, MG.;   
Hancock, REW.  (2005)  Impact of LL-37 on anti-infective 
immunity.  J. Leukoc Biol.  77:451-459 
[65]  Finlay, BB.;  Hancock, REW.  (2004)  Can innate immunity be  
enhanced to treat infections?.  Nat Rev Microbiol.  2: 497-504 
 
 
111 
 
[66]  Hiemstra, PS.;  Ferrie-King, BA.;  McMichael, J.;  Lachmann, PJ.;   
Sallenave, JM.  (2004)  Antimicrobial peptides: mediators of 
innate immunity as templates for the development of novel anti-
infective and immune therapeutics.  Curr Pharm Des.  10: 2891-
2905 
[67]  Baker, MA.;  Maloy, WL.;  Zasloff, M.;  Jacob, L.S.  (1993)  Anticancer  
efficacy of magainin 2 and analogue peptides.  Cancer Res.  53: 
3052-3057 
[68]  Ganz, T.  (1999)  Defensins and host defense.  Science 286: 420-421 
[69]  Carlsson, A.; Engström, P.;  Palva, ET.;  Bennich, H.  (1991)  Attacin,  
an antibacterial protein from Hyalophora cecropia, inhibits 
synthesis of outer membrane proteins in Escherichia coli by 
interfering with omp gene transcription.  Infect. Immun.  59: 
3040-3045 
[70]  Park, CB.;  Kim, HS.;  Kim, SC.  (1998)  Mechanism of action of the  
antimicrobial peptide buforin II:  buforin II kills microorganisms 
by penetrating the cell membrane and inhibiting cellular 
functions.   Biochem.  Biophys.  Res. Commun.  244: 253-257 
[71]  Otvos Jr, L.;  Insug, O.;  Rogers, ME.;  Consolvo, PJ.;  Condie, BA.;   
Lovas, S.;  Bulet, P.;  Blaszczyk-Thurin, M.  (2000)  Interaction 
between Heat Shock Proteins and Antimicrobial Peptides.  
Biochemistry.  39:14150-14159 
 
 
112 
 
[72]  Hancock, REW.;  Sahl, HG.  (2006)  Antimicrobial and host defense  
peptides as new anti-infective therapeutic strategies.  Nature 
Biotechnol.  24:1551-1557. 
[73]  Giuliani, A.; Pirri, G.;  Nicoletto, SF.  (2007)  Antimicrobial peptids: an  
overview of a promising class of therapeutics.  Central Euro J. of 
Biol.  1:1-33 
[74]  Oppenheim, F. G.; Yang, Y.-C.; Diamond, R. D.; Hyslop, D.; Offner, G.  
D.; Troxler,R. F. (1986) The primary structure and functional 
characterization of the neutral histidine-rich polypeptide from 
human parotid secretion. J. Biol. Chem. 261:1177–1182. 
[75]  Oppenheim, F. G.; Xu, T.; McMillian, F. M.; Levitz, S. M.; Diamond, R.  
D.; Offner, G. D.; Troxler, R. F. (1988) Histatins, a novel family 
of histidine-rich proteins in human parotid secretion. J. Biol. 
Chem.  263:7472–7477. 
[76]  Kavanagh K.; Dowd, S.  (2004)  Histatins: antimicrobial peptides  
with therapeutic potential.  J Pharm Pharmacol 56:285-289 
[77]  Helmerhorst, EJ.; van’t Hof, W.;  Veerman, ECI.;  Simoons- 
Smit, I.;  Nieuw, AV.  (1997)  Synthetic histatin analogues with 
broad-spectrum antimicrobial activity.  Biochem J.  326:39-45 
[78]  Edgerton, M.;  Koshlukova, S.;  Lo, T.; Chrzan, BG.;   
Straubinger, RM.;  Raj, PA.  (1998)  Candidacidal activity of 
salivary histatins.  Identification of a histatin 5-binding protein 
on Candida albicans  J. Biol. Chem.  32:20438-20447 
 
113 
 
[79]  Murakami, Y.;  Xu, T.;  Helmerhorst, EJ.;  Ori, G.;  Troxler, RF.;  Lally,  
ET.;  Oppenheim, FG.  (2002)  Inhibitory effect of synthetic 
histatin 5 on leukotoxin from  Actinobacillus 
actinomycetemcomitans.  Oral Microbiol Immun. 17:143-149 
[80]  Sabatini, L. M.; Ota, T.; Azen, E. A. (1993)   Nuleotide sequence  
analysis of the human salivary protein genes HIS1 and HIS2, 
and evolution of the STATH/HIS gene family. Mol. Biol. Evol.  
10:497–511. 
[81]  Xu, L.; Lai, K.; Santarpia, R. P.; Pollock, J. J.  (1993)  Salivary  
proteolysis of histidine-rich polypeptides and the antifungal 
activity of peptide degradation products. Arch. Oral Biol. 38: 
277–283 
[82]  Edgerton, M.; Koshlukova, S. E.; Lo, T. E.; Chrzan, B. G.;  
Straubinger, R. M.; Raj, P.A.  (1998)  Candidacidal activity of 
salivary histatins. J. Biol. Chem. 273: 20438–20447 
 [83]  Koshlukova, S. E.; Lloyd, T. L.; Araujo, M. W. B.; Edgerton, M. (1999)   
Salivary Histatin 5 induces non-lytic release of ATP from 
Candida albicans leading to cell death. J. Biol. Chem. 274: 
18872–18879 
[84]  Li, X. S.; Reddy, M. S.; Baev, D.; Edgerton, M. (2003)  Candida  
albicans Ssa1/2p is the cell envelope binding protein for human 
salivary histatin 5. J. Biol. Chem.  278: 28553–28561 
 
 
114 
 
[85]  Baev, D.; Rivetta, A.; Vylkova, S.; Sun. J. N.; Zeng, G.-F.; Slayman, C.  
L.; Edgerton, M. (2004)  The TRK1 potassium transporter is the 
critical effector for killing of Candida albicans by the cationic 
protein, histatin 5. J. Biol. Chem.  279: 55060–55072. 
[86]  Helmerhorst, E. J.; Troxler, R. F.; Oppenheim, F. G. (2001)  The human  
salivary peptide histatin 5 exerts its antifungal activity through 
the formation of reactive oxygen species. Proc. Nat. Acad. Sci.  
98: 14637–14642.  
[87]  Helmerhorst, E. J.; Breeuwer, P.; van’t Hof, W.; Walgreen-Weterings,  
E.; Oomen, L. C. J. M.; Veerman, E. C. I.; Amerongen, A. V. N.; 
Abee, T. (1999)  The cellular target of histatin 5 on Candida 
albicans is the energized mitochondrion. J. Biol. Chem.  274: 
7286–7291. 
[88]  Mochon, A.B.;  Liu, H.  (2008)  The Antimicrobial peptide Histatin-5  
Causes a Spatially Restricted Disruption on the Candida albicans 
Surface, Allowing Rapid Entry of the Peptide into the Cytoplasm.  
PloS Pathog.  4(10) 
[89]  Glusker, J.P.  (1991)  Structural aspects of metal liganding to functional  
groups in proteins.  Adv. Protein Chem.  42: 1-76 
[90]  Todd, R.J.;  Van Dam, M.E.;  Casimiro, D.;  Haymore, B.L.;  Arnold,  
F.H.  (1991)  Cu(II)-binding properties of a cytochrom c with a 
synthetic metal-binding site: His—X3—His in an alpha-helix.  
Proteins.  10:156-161 
 
115 
 
[91]  Peters Jr., T.  (1960)   Interaction of one mole of copper with the  
alpha amino group of bovine serum albumin. Biochim. Biophys. 
Acta.  39:546–547. 
[92]  Gusman, H.;  Lendenmann, U.;  Grogan, J.;  Troxler, R.F.;   
Oppenheim, F.G.  (2000)  Is salivary Histatin-5 a 
metallopeptide?  Biochimica et Biophysica Acta  1545:86-95 
[93]  Melino, S.;  Gallo, M.;  Trotta, E.;  Mondello, F.;  Paci, M.;  Petruzzelli,  
R.  (2006)  Metal-binding and nuclease activity of an 
Antimicrobial peptide analogue of the Salivary Histatin-5.  
Biochem.  45:15373-15383 
[94]  Brewer, D.;  Lajoie, G.  (2000)  Evaluation of the metal binding  
properties of the histidine-rich antimicrobial peptides histatin 3 
and 5 by electrospray ionization mass spectrometry.  Rapid 
Comm. In Mass Spec.  14: 1736-1745 
[95]  Tsai, H.;  Raj, PA.;  Bobek, LA.  (1996)  Candidacidal activity of  
recombinant human salivary histatin-5 and variants.  Infect 
Immun.  64: 5000-5007 
[96]  Melino, S.;  Rufini, S.;  Sette, M.;  Morero, R.;  Grottesi, A.;  Paci, M.;   
Petruzzelli, R.  (1999)  Zn2+ Ions Selectively Induce 
Antimicrobial Salivary Peptide Histatin-5 Fuse Negatively 
Charged Vesicles.  Identification and Characterization of a Zinc-
Binding Motif Present in the Functional Domain.  Biochem.  30: 
9626-9633 
 
116 
 
[97]  Tay, W.M.  (2008)  Metallopeptidases As Model Systems for the Study  
of Cu(II)-Dependent Oxidation Chemistry.  University of South 
Florida 
[98]  Peters Jr., T.;  Blumenstock, F.  (1967)  Copper-binding Properties of  
Bovine Serum Albumin and Its Amino Terminal Fragment.  J. of 
Biol. Chem.  242: 1574-1578 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
117 
 
 
 
 
 
 
 
 
 
 
 
 
Appendices 
 
 
 
 
 
 
 
 
 
118 
 
Appendix A:   Pertinent information and Protocols regarding  
SgAP project using E. coli expression system 
A-1:   Streptomyces griseus aminopeptidase (SgAP) nucleotide  
 sequence: 
 
     GGTACCGCCC GGACGGCCCG CTCAGCCGCC AGGAGGTCGC CGACCACCTC GCGGACCTGC 
     TGCTGCGGGC CCTGCGCCCG TAGCGGGGGT ACGGGGCCGG CCGGCGGATC TCGCTACCCA 
     CTGGCCCGCT CCGCCGGTCG GGGTGAGTCT GGATACATGA CGTATGTCCT GCCTCCCGAT 
     GGGGCGCCGG GGTTCACGGG CGAACCACTG TTCGTTAATA GAACGGCTAT GTCCGGTTTC 
     CGCTCTTGAC GGAGCACTGT CATTTCCTTG AGCATCGGTC ACGCATTGCG CACCTCTGGG 
     CCGCTTGTCG GGCCCACGCT CCAGGACCCG GCCGGATCAC CGCGCGGCCG GGGACCCCCC 
     GCACGTTCCG TCAGTCCCCA ACGGAATCCG GAGCCCGTGA ATGAGACCGA ACCGCTTCTC 
     CCTGCGCAGA TCCCCGACGG CCGTCGCCGC CGTGGCCCTC GCCGCCGTCC TCGCGGCCGG 
     TGCCCCGGCC GCCCAGGCCG CCGGCGCCGC GGCCCCGACG GCAGCCGCCG CGGCCGCGCC 
     CGACATCCCC CTGGCCAACG TCAAGGCCCA CCTCACGCAG CTCTCGACGA TCGCCGCGAA 
     CAACGGCGGC AACCGCGCCC ACGGCCGCCC CGGCTACAAG GCGTCCGTCG ACTACGTGAA 
     GGCCAAGCTC GACGCGGCCG GATACACCAC CACGCTCCAG CAGTTCACCT CGGGCGGGGC 
     CACCGGCTAC AACCTGATAG CCGACTGGCC CGGCGGCGAC CCCAACAAGG TCCTGATGGC 
     CGGGGCCCAC CTCGACTCGG TCTCCTCCGG CGCCGGGATC AACGACAACG GCTCCGGCTC 
     GGCCGCCGTG CTGGAGACCG CGCTCGCCGT CTCCCGCGCC GGGTACCAGC CCGACAAGCA 
     CCTGCGGTTC GCCTGGTGGG GCGCGGAGGA GCTGGGCCTG ATCGGCTCGA AGTACTACGT 
     CAACAACCTG CCGTCCGCCG ACCGCTCCAA GCTCGCCGGA TATCTCAACT TCGACATGAT 
     CGGCTCGCCC AACCCCGGTT ACTTCGTCTA CGACGACGAC CCGGTCATCG AGAAGACCTT 
     CAAGGACTAC TTCGCCGGCC TGAACGTCCC GACCGAGATC GAGACCGAGG GCGACGGCCG 
     CTCCGACCAC GCCCCGTTCA AGAACGTCGG CGTCCCCGTC GGCGGACTCT TCACCGGCGC 
     CGGCTACACC AAGTCCGCCG CCCAGGCGCA GAAGTGGGGC GGGACGGCCG GGCAGGCCTT 
     CGACCGCTGC TACCACTCCT CGTGCGACAG CCTGAGCAAC ATCAACGACA CCGCCCTGGA 
     CCGCAACAGC GACGCCGCCG CCCACGCGAT CTGGACCCTG TCCTCCGGCA CCGGCGAACC 
     GCCCACCGGC GAGGGCGTCT TCAGCAACAC CACGGACGTG GCCATCCCGG ACGCCGGGGC 
     CGCGG 
 
 
 
 
 
 
 
 
 
119 
 
Appendix A (Continued) 
A-2:   Translated active SgAP aligned with translated active ScAP    
SgAP      APDIPLANVKAHLTQLSTIAANNGGNRAHGRPGYKASVDYVKAKLDAAGYTTTLQQFTSG  
ScAP      APDIPIANVKAHLRQLESIATANGGNRAHGRAGYRASLDYMKAKLDAAGFTTRVQQFSAS  
          *****:******* **.:**: *********.**:**:**:********:** :***::. 
 
SgAP      GATGYNLIADWPGGDPNKVLMAGAHLDSVSSGAGINDNGSGSAAVLETALAVSRAGYQPD  
ScAP      GRTGYNLTADWPGGDASQIVMAGSHLDSVASGPGINDNGSGSSAVLETALAVARSGYQPT  
          * ***** *******..:::***:*****:**.*********:*********:*:****  
 
SgAP      KHLRFAWWGAEELGLIGSKYYVNNLPSADRSKLAGYLNFDMIGSPNPGYFVYDDDPVIEK  
ScAP      KHLRFAWWGAEELGLVGSRYYVNSLGSAERAKISGYLNFDMIGSPNPGYFVYDDDPTIEK  
          ***************:**:****.* **:*:*::**********************.*** 
 
SgAP      TFKDYFAGLNVPTEIETEGDGRSDHAPFKNVGVPVGGLFTGAGYTKSAAQAQKWGGTAGQ  
ScAP      TFKDYFSGIGISTEIETEGDGRSDHAPFKNAGVPVGGLFSGADYRKTSAQAAKWGGTVGQ  
          ******:*:.:.******************.********:**.* *::*** *****.** 
 
SgAP      AFDRCYHSSCDSLSNINDTALDRNSDAAAHAIWTLSSGTGEPPTGEGVFSNTTDVAIPDA  
ScAP      PFDRCYHSSCDTTANIDDTALDRNSDAIAYAVWELSQ-----------------------  
          .**********: :**:********** *:*:* **.                        
 
SgAP      GAA  
ScAP      --- 
*=Identical;  :=conserved substitution; .=semi-conserved substitution 
A-3:  Streptomyces coelicolor Aminopeptidase (ScAP) Nucleotide  
Sequence 
     CTACTGCGAC AGTTCCCAGA CCGCGTAGGC GATGGCGTCG CTGTTGCGGT CCAGGGCCGT 
     GTCGTCGATG TTGGCGGTCG TGTCGCAGGA CGAGTGGTAG CAGCGGTCGA AGGGCTGGCC 
     CACGGTGCCG CCCCACTTGG CCGCCTGCGC GGACGTCTTG CGGTAGTCCG CGCCGCTGAA 
     GAGGCCGCCC ACGGGGACGC CCGCGTTCTT GAAGGGTGCG TGGTCGGAGC GTCCGTCGCC 
     CTCGGTCTCG ATCTCCGTGG AGATGCCGAT CCCGCTGAAG TAGTCCTTGA ACGTCTTCTC 
     GATCGTGGGA TCGTCGTCGT AGACGAAATA GCCGGGGTTG GGCGAGCCGA TCATGTCGAA 
     GTTCAGGTAA CCGCTGATCT TCGCGCGTTC CGCGGAGCCG AGGCTGTTGA CGTAGTAGCG 
     GGAGCCGACG AGTCCCAGCT CCTCCGCGCC CCACCAGGCG AAGCGCAGGT GCTTCGTCGG 
     CTGGTAGCCG GACCGGGCGA CGGCGAGCGC GGTCTCCAGG ACGGCCGAGG AGCCGGAACC 
     GTTGTCGTTG ATGCCGGGCC CGGAGGCGAC ACTGTCCAGA TGTGACCCGG CCATGACAAT 
     CTGACTCGCG TCGCCGCCGG GCCAGTCGGC CGTCAGGTTG TACCCGGTGC GGCCCGAGGC 
     GCTGAACTGC TGGACGCGGG TGGTGAACCC GGCGGCGTCC AGCTTGGCCT TCATGTAGTC 
     GAGGGAGGCC CGGTAGCCGG CGCGGCCGTG GGCGCGGTTG CCGCCGTTCG CCGTGGCGAT 
     CGACTCCAGC TGCCTCAGAT GGGCCTTGAC GTTGGCTATC GGTATGTCGG GCGCGGCGGC 
     GGCAGCGGCA GTGCCGGTGG GGGTGGCGGG GTGCACGGGC GCGGACGCCG CACCGGCGGC 
     GGAACCGCCG GCCATCAGTG TGACGACGGC GACGGCTCCG GCCGTCAGTG CGCGCCCGGA 
     AGGGAGGAGC TGCAT 
Highlighted regions correspond to PCR primer binding sites. 
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Appendix A (Continued) 
PCR Protocol for obtaining insert from S. coelicolor genomic DNA 
Master Mix (for single sample)  *Done in PCR hood 
1) Nano pure Water 28.0μL 
2) 5x Taq Master  10.0μL (must first be thawed 15min at 65°C) 
3) 10x Taq Buffer  5.00μL 
4) 10.0mM dNTP  1.00μL 
5) 5’-primer   0.50μL  (stock solution 55.1μM) 
6) 3’-primer   0.50μL (stock solution 40.4μM) 
7) Taq Polymerase  0.50μL 
PCR Sample Tubes  *Done in PCR Hood 
1) Master Mix  46.5μL 
2) Nano pure Water 1.50μL 
3) Mg2+   1.00μL 
4) Genomic DNA  1.00μL *Not added in PCR Hood (Need to 
find concentration of this) 
PCR Cycles 
1)  Hold at 95°C for 3.5 minutes 
2) Heat to 95°C for 30 seconds 
3) Cool to 50°C and hold for 30 seconds 
4) Heat to 72°C and hold for 1.5 minutes 
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Appendix A (Continued) 
5) Repeat steps 2-4 for a total of 35 cycles 
6) Hold at 72°C for 10minutes 
7) Cool to 4°C until removed and stored for future use 
Purifying DNA using Amicon Spin Columns 
1) Place spin column on tube. 
2) Add 300μL nano pure water into reservoir 
a. Adjust based on sample but no less than 300, so total 
volume is 400μL 
3) Add no more than 100μL sample reaction to reservoir 
4) Place assembled device into centrifuge with cap strap inward 
5) Centrifuge at 1000xg for 15 minutes 
6) Remove from centrifuge , save filtrate until sample has been 
analyzed 
7) Place reservoir upright into clean vial.  Add 20μL TE. 
8) Invert reservoir into the clean vial and centrifuge at 1000xg for 2 
minutes. 
9) The sample should now be pure and ready for downstream 
applications 
 
 
 
Appendix A (Continued) 
A-4:  pQE-30 Xa Vector Map from “The Qiaexpressionist” 
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Appendix A (Continued) 
Restriction Digest Protocol 
 Vector Digest 
 Add to 0.65mL Eppendorf Tube: 
1) Nano Pure Water  67.0μL  
2) pQE-30 Xa   20.0μL (Stock Solution at 189ng/μL) 
3) Buffer B     10.0μL 
4) BSA    2.00μL 
5) XmaI    0.50μL 
Then: 
1) Place in 37°C Water bath for 6.0 hours 
2) Add 0.50μL StuI 
3) Return to 37°C Water bath for 16.0 hours 
4) Purify product using Amicon Spin Columns (see above) 
Insert Digest 
Add to 0.65mL Eppendorf Tube: 
1) Nano Pure Water  33.0μL 
2) Insert DNA   10.0μL 
3) Buffer B    5.00μL 
 
Appendix A (Continued) 
4) BSA    1.00μL 
5) XmaI    1.0μL 
Then: 
1) Incubate at 37°C for 6 hours 
2) Purify using Amicon Spin Columns (See Above) 
Ligation Protocol 
Ligation Buffer: 
1) Nano Pure Water 22.5μL 
2) 1.0M Tris pH 7.5 50.0μL 
3) 1.0M DTT  10.0μL 
4) 100mM ATP  10.0μL 
5) MgCl2   5.00μL 
6) BSA   2.50μL 
 
Reaction Tubes: 
1) Nano Pure Water 24.9μL 
2) Ligation Buffer  3.00μL 
3) Ligase   1.00μL 
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Appendix A (Continued) 
4) Insert   2.57μL (Concentration 202.5ng/μL) 
5) Vector   0.50μL (Concentration 202.5ng/μL) 
This creates a 20:1 ratio, 20 inserts per vector 
Then: 
1)  Hold at 17.0°C for 14-18 hours 
2) Proceed to Transformation without purification 
Transformation Protocols 
 XL1-Blue Transformation 
1) Thaw glycerol stocks of cell line (stored at -80°C) on Ice 
2) Place 1.5mL eppendorf tubes on ice to pre-chill 
3) Add 80μL XL1-Blue to 1.5mL Eppendorf tube 
4) Add 2.00μL ligation reaction product 
5) Mix well by flicking or brief vortexing 
6) Hold on ice for 30.0 minutes 
7) Heat shock at 42°C for 45 seconds 
8) Replace in ice for 2.0 minutes 
9) Pipette 41.0μL onto agar plate with antibiotics (Ampicilin at 
100μg/mL) 
a. Two plates per transformation 
10) Grow at 37°C for approximately 24 hours 
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Appendix A (Continued) 
Rosetta Blue Transformation and BL21 Transformation 
1) Thaw glycerol stocks of cell line (stored at -80°C) on Ice 
2) Place 1.5mL eppendorf tubes on ice to pre-chill 
3) Add 20.0μL Rosetta Blue thawed cells to 1.5mL Eppendorf tube 
4) Add 1.00μL ligation reaction product 
5) Mix well by flicking or brief vortexing 
6) Heat shock at 42°C for 45 seconds 
7) Incubate on Ice for 2.0 minutes 
8) Add 80.0μL room temperature SOC medium 
9) Shake at 250rpm, 37°C for 1 hour 
10) Dilute transformation into more SOC medium 
a. 10μL transformation with 30μL SOC, total volume of 40μL 
b. 20μL transformation with 20μL SOC, total volume of 40μL 
11) Spread onto LB-AMP agar plates and incubate at 37°C for 
approximately 24 hours 
3mL overnight culture protocol 
1) Add 3mL LB-AMP (100μg/mL) broth to sterilized test tube 
2) Pick single colony off agar plate using sterilized toothpick 
3) Add toothpick to 3mL LB-AMP broth in test tube 
4) Shake in incubator at 300rpm, 37°C for 16-18 hours (overnight) 
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Crude Mini Prep Protocol 
1) Centrifuge 1.0-1.5mL of 3.0mL overnight culture at 14,000xg for 
1.0 minute 
2) Decant supernatant, remove residual supernatant with pipette 
3) Add 150μL Buffer P1 (with RNase A).  Resuspend by vortexing 
4) Add 150μL Buffer P2.  Invert to mix.  Hold at room temperature 5.0 
minutes 
5) Add 150μL Buffer P3.  Invert to mix.  Hold on Ice 5.0 minutes 
6) Centrifuge at 14,000xg, 4°C for 10.0 minutes 
7) Add supernatant to 1.0mL ethanol (100%).  Incubate -80°C for 1 
hour 
8) Centrifuge at 14,000xg, 4°C for 15.0 minutes 
9) Decant supernatant.  Wash pellet with 200μL 70% ethanol 
10) Centrifuge at 14,000xg for 5.0 minutes 
11) Decant 70% ethanol supernatant and air dry pellet 
12) Add 30μL TE and dissolve pellet 
Perfect Mini Prep Protocol 
1) Centrifuge 1.0-1.5mL of 3.0mL overnight culture at 14,000xg for 
1.0 minute 
2) Decant supernatant, remove residual supernatant with pipette 
3) Add 100μL Solution 1 to the cell pellet.  Resuspend by vortexing 
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Appendix A (Continued) 
4) Add 100μL Solution 2.  Invert to mix. 
5) Add 100μL Solution 3.  Invert to mix. 
6) Centrifuge at 14,000xg for 30 seconds.  Transfer supernatant to 
spin column. 
7) Vigorously and thoroughly mix the DNA binding matrix suspension 
before pipetting. 
8) Add 450μL DNA binding matrix to the supernatant in the spin 
column.  Mix by capping the spin column and inverting vigorously 
9) Centrifuge the spin column assembly at 14,000xg for 30 seconds.  
Decant filtrate and replace spin column into the collection tube. 
10) Add 400μL DILUTED purification solution to same spin column.  
Cap the tube, shake briefly and centrifuge at 14,000xg for 60 
seconds 
11) Decant filtrate and place spin column back into collection tube.  
Centrifuge at 14,000xg for 60 seconds to remove residual 
Purification solution. 
12) Transfer spin column to fresh collection tube.  Add 50-70μL of 
Elution Buffer directly to the DNA binding matrix in the spin 
column.  Cap the assembly and vortex briefly. 
13) Centrifuge at 14,000xg for 60 seconds. 
 
 
Appendix A (Continued) 
14) Discard  spin column and cap the collection tube.  Eluted plasma 
DNA is ready for downstream applications or can be stored at -
20°C. 
Agarose Gel Electrophoresis 
Preparing the Gel (0.7%) 
 Add to microwave safe Erlenmeyer Flask 
1) 1X TAE 50mL (Volume Varies by gel rig) 
2) Agarose 0.35g  (depends on gel percentage) 
a.  
3) Swirl to Mix 
4) Microwave on High for 15 second intervals, swirling between 
intervals, until all agarose has dissolved. 
5) Let cool 1-2 minutes, add 20μL ethidium bromide 
6) Pour into gel rig, with comb, and let rest until polymerization is 
complete 
Running Conditions (general, may be adjusted as needed by samples) 
1) 150 Volts 
2) 35 minutes 
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Appendix A (Continued) 
Overexpression protocol 
1) To sterilized Erlenmeyer flask (250mL for this example) add 99mL 
Fresh LB-AMP (100μg/mL) broth 
2) Add 1.0mL of 3.0mL overnight culture to 100mL Fresh LB-AMP 
3) Shake in incubator at 300rpm, 37°C until OD=0.4-0.6, use 1.0mL 
Fresh LB-AMP to blank spectrophotometer. 
a. While growing make IPTG solution. 
b. Add 0.024g IPTG to 3.0mL LB-AMP broth, invert to dissolve 
i. Makes 3mL of 33.6mM solution 
4) Take “uninduced” sample, 1.0mL.  Centrifuge at 14,000xg for 1.0 
minute, remove supernatant and re-suspend pellet in 50μL SDS-
PAGE loading buffer.   
a. Put sample in boiling water bath for 5-7 minutes 
5) Add IPTG solution, so final concentration is 1mM 
a. Based on above, add 3mL IPTG solution to 98mL culture 
(99mL (Fresh LB-AMP)+1.0mL (Overnight Culture) -1.0mL 
(to test OD)-1.0mL (for uninduced sample) 
b. Optional to take time point samples at 1, 2, 3, 4 etc. hours 
6) Centrifuge remainder at 10,000xg for 20min to pellet cells. 
7) Store in -20°C until ready for use for purification 
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Purification of ScAP under denaturing (for insoluble fraction) 
conditions 
1) Thaw cells on Ice for 15.0-20.0 minutes 
2) Re-suspend pellet in 15mL bacterial cell wall lysis buffer (for a 
100mL overexpression sample) by vortexing or pipetting.   
a. 2-5mL cell wall lysis buffer per gram wet pellet weight 
3) Add 1.7 mg lysozyme per mL of cell wall lysis buffer  
a. Optional to add protease inhibitors: 
i. 250μL 10mM PMSF 
ii. 250μL 10mM Benzamidine 
4) Shake on ice for 60.0 minutes 
5) Sonicate 60 seconds, take sample for SDS-PAGE 
6) Pellet cells at 10,000xg, 4°C, 20 minutes.   
a. Save supernatant for SDS-PAGE 
7) Add 15mL Urea buffer to cell pellet and resuspend.   
a. Take sample for SDS-PAGE 
8) Incubate 1.0 hour at 37°C shaking at 200rpm.  Take sample for  
a. SDS-PAGE 
9) Centrifuge at 10,000xg, 4°C, 20 minutes 
10) Add 1mL Ni-NTA Agarose, shake on ice 45.0 minutes 
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11) Add to column and collect flow through.   
a. Take sample for SDS-PAGE 
12) Wash 2x 4mL with Buffer C (pH 6.3) 
a. Take sample for SDS-PAGE 
13) Elute with 2mL Buffer D (pH 5.9) 
a. Take sample for SDS-PAGE 
14) Elute with 2mL Buffer E (pH 4.5) 
a. Take sample for SDS-PAGE 
15) Run samples from above on SDS-PAGE.  Purpose: 
a. Find target protein and Determine which elution fraction has 
bulk of target protein 
b. Ensure purification is working properly 
c. Determine if any modifications need to be made. 
16) Optional modifications include 
a.  adjust the volumes for washing or eluting. 
b. More or less Ni-NTA Agarose 
c. Adjusting volume of Urea Buffer 
d. Replacing Urea Buffer with Guandine Buffer 
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Purification of ScAP insoluble fraction using Detergents to denature 
1) Thaw cells on Ice for 15.0-20.0 minutes 
2) Re-suspend pellet in 15mL bacterial cell wall lysis buffer (for a 
100mL overexpression sample) by vortexing or pipetting.   
a. 2-5mL cell wall lysis buffer per gram wet pellet weight 
3) Add 1.7 mg lysozyme per mL of cell wall lysis buffer  
a. Optional to add protease inhibitors: 
i. 250μL 10mM PMSF 
ii. 250μL 10mM Benzamidine 
4) Shake on ice for 60.0 minutes 
5) Sonicate 60 seconds, take sample for SDS-PAGE 
6) Pellet cells at 10,000xg, 4°C, 20 minutes.   
a. Save supernatant for SDS-PAGE 
7) Resuspend pellet in 10mL Cell Wall Lysis Buffer (no lysozyme) with 
30μL Tween-20 (0.3%) 
a. Also tried .1% Tween-20 
8) Add Stir bar and stir vigorously in fridge for 4 hours 
9) Add 5 grams SM-2 Bio-Beads and stir in fridge overnight 
10) Centrifuge at 10,000xg, 4°C for 20 minutes 
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Another Purification protocol using detergents to denature 
1) Thaw cells on Ice for 15.0-20.0 minutes 
2) Re-suspend pellet in 15mL bacterial cell wall lysis buffer (for a 100mL 
overexpression sample) by vortexing or pipetting.   
a. 2-5mL cell wall lysis buffer per gram wet pellet weight 
3) Add 1.7 mg lysozyme per mL of cell wall lysis buffer  
a. Optional to add protease inhibitors: 
i. 250μL 10mM PMSF 
ii. 250μL 10mM Benzamidine 
4) Shake on ice for 60.0 minutes 
5) Sonicate 60 seconds, take sample for SDS-PAGE 
6) Pellet cells at 10,000xg, 4°C, 20 minutes.   
a. Save supernatant for SDS-PAGE 
7) Resuspend pellet in 10mL Cell Wall Lysis Buffer (no lysozyme) with 
30μL Tween-20 (0.3%) 
a. Also tried .1% Tween-20 
8) Add Stir bar and stir vigorously in fridge for 4 hours 
9) Add 5 grams SM-2 Bio-Beads and stir in fridge overnight 
10) Remove liquid with as few biobeads as possible and run through 
column to remove remaining biobeads 
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11) Add 1mL Ni-NTA Agarose to flow through and shake on ice for 
45.0 minutes 
12) Add to column collect flow through, wash and elute as for 
soluble fraction (see below) 
Purification of ScAP under native (soluble fraction) conditions 
1) Thaw cells on Ice for 15.0-20.0 minutes 
2) Re-suspend pellet in 15mL bacterial cell wall lysis buffer (for a 
100mL overexpression sample) by vortexing or pipetting.   
a. 2-5mL cell wall lysis buffer per gram wet pellet weight 
3) Add 1.7 mg lysozyme per mL of cell wall lysis buffer  
a. Optional to add protease inhibitors: 
i. 250μL 10mM PMSF 
ii. 250μL 10mM Benzamidine 
4) Shake on ice for 60.0 minutes 
5) Sonicate 60 seconds 
a. Take sample for SDS-PAGE 
6) Pellet cells at 10,000xg, 4°C, 20 minutes. 
7) Supernatant is soluble protein fraction.   
a. Take sample for SDS-PAGE 
8) Add 1.0 mL Ni-NTA agarose to supernatant in Erlenmeyer flask. 
9) Shake on Ice for 45.0 minutes 
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10) Add to column and collect flow through 
a. Take sample for SDS-PAGE 
11) Wash 2x4mL with Wash buffer 
a. Take sample for SDS-PAGE 
12) Elute 4x0.5mL with Elute buffer 
a. Take Sample for SDS-PAGE 
13) Run SDS-PAGE 
14) Optional modifications include 
a.  adjusting the volumes for washing or eluting. 
b. More or less Ni-NTA Agarose 
Cell Wall Lysis Buffer 
1) 50.0mM NaH2PO4 
2) 1.0M NaCl 
3) 10.0mM imidazole 
4) pH 8.0 
Urea Buffer (insoluble fraction) 
1) 8M Urea 
2) 100mM NaH2PO4 
3) Triton X-100 (500μL per 50mL total volume) 
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4) 10.0mM Tris pH 8. 
5) Adjust pH to 8 using NaOH 
Guanidine Buffer (insoluble fraction) 
1) 6M Guanidine 
2) 100.0mM NaH2PO4 
3) 10.0mM Tris 
4) Adjust pH to 8.0 
Buffers C, D, and E (insoluble fraction) 
1) 100mM NaH2PO4 
2) 10mM Tris-CL 
3) 8M Urea (6M Guanidine can be substituted) 
a. Buffer C pH adjusted to 6.3 
b. Buffer D pH adjusted to 5.9 
c. Buffer E pH adjusted to 4.5 
Wash Buffer (soluble fraction) 
1) 50mM NaH2PO4 
2) 300mM NaCl 
3) 20mM imidazole  
4) Adjust pH to 8.0 using NaOH 
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Elution Buffer (soluble fraction) 
1) 50mM NaH2PO4 
2) 300mM NaCl 
3) 250mM imidazole  
4) Adjust pH to 8.0 using NaOH 
Protein Refolding for insoluble fraction after purification  
Protocol Basic Refolding protocol 
1) Add appropriate fraction (based on SDS-PAGE) into dialysis bag 
2) Place dialysis bag (Approximately 2mL) in 150mL beaker with 
Dialysis Buffer 
a. 50.0mM Tris 
b. 100.0mM NaCl 
c. Adjust pH to 8.0 
d. Possible modifications 
i. 50mM Glycine 
ii. 2mM Beta-mercaptoethanol 
iii. Also substituted 50.0mM Tris with 100mM HEPES 
3) Change buffer 4 times with at least 4 hours in between changes 
4) Potential modifications 
a. Adding 50μM ZnCl2 
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Appendix A (Continued) 
b. Adding 1mM CaCl2 
c. pH 7.5 
d. Diluting the appropriate fraction 
i. Ex. 1mL Fraction E + 39mL fresh Buffer E placed into 
dialysis bag and dialyzed against Dialysis buffer (note 
that this requires a larger beaker for dialysis and 
therefore more dialysis buffer 
ii. Also tried 2mL Fraction E +198mL Buffer E 
iii. The goal of this was to prevent the protein from 
precipitating with the fast removal of denaturant (Urea 
or Guanidine 
e. Use a stepwise removal of denaturant 
i. Dialysis buffer one contains 6M urea, 
ii. Dialysis buffer two contains 3M urea, 
iii. Dialysis buffer three contains 1M Urea 
iv. Dialysis buffer four contains no urea, etc. 
Renaturation Protocol 
1) Dilute 2mL Buffer E into 98mL Renaturation Buffer 
a. 20mM Tris 
b. 100mM NaCl 
c. pH 8.0 
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Appendix A (Continued) 
2) Shake on Ice 30.0 min 
3) Add 1mL Ni-NTA Agarose 
4) Shake on Ice 30.0 min 
5) Add to column and collect flow through 
6) Elute with 2mL Elution buffer (Same as for soluble fraction 
purification “Elution Buffer” see above) 
7) Dialyzed against 2x250mL Buffer 
a. 20mM Tris 
b. 100mM NaCl 
c. 50μM ZnCl2 
d. 1mM CaCl2 
e. pH 8 
Modified Renaturation Protocol 
1) Instead of eluting insoluble fraction from column with Elution 
Buffer, add 5-10mL acetone/Guanidine buffer but do not run 
through column.   
a. 1.4M Acetone 
b. 0.7M Guanidine 
c. 1mM CaCl2 
d. 50μM ZnCl2 
e. pH 8.5 
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Appendix A (Continued) 
2) Swirl or pipette up and down to suspend His-tagged protein-Ni-NTA 
Agarose complex into the acetone/Guanidine buffer and remove 
from column. 
3) Add to 40-45mL acetone/Guanidine buffer (total volume approx. 
50mL) 
4) Shake at 150rpm, 35°C for 1.0 hour 
5) Add back to column and collect flow through 
6) Elute from column with 2mL Elution Buffer (Same as for soluble 
fraction purification “Elution Buffer” see above) 
7) Dialyze against 2x250mL Buffer 
a. 20mM Tris 
b. 100mM NaCl 
c. 50μM ZnCl2 
d. 1mM CaCl2 
e. pH 8 
Another renaturation attempt 
1) Elute from column with Buffer E as stated in insoluble fraction 
purification protocol 
2) Refold in Acetone/Guanidine buffer, shake at 150rpm, 35°C for 1.0 
hour 
3) Add 1mL Ni-NTA Agarose, shake on ice for 45.0 minutes 
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Appendix A (Continued)  
4) Add to column, collect flow through 
5) Elute with 2mL Elution buffer (Same as for soluble fraction 
purification “Elution Buffer” see above) 
Western Blotting Protocol 
1) Perform SDS-PAGE, 150 volts for 1.5 hours 
2) Equilibrate Membrane  
a. 3 seconds Methanol,  
b. 1-2 minutes H2O,  
c. 5-10 minutes western transfer buffer 
3) Equilibrate Gel 
a. 5 minutes H2O 
b. 10 minutes western transfer buffer 
4) Soak pad and paper for transfer in western transfer buffer 
5) Assemble western transfer apparatus: 
a. Black side 
b. Pad 
c. Paper 
d. Gel 
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e. Membrane 
f. Paper 
g. Pad 
h. Clear 
6) Run in apparatus with ice pack and stir bar, 1.0 hour and 100 volts 
7) Soak in 200mL 1X-PBS blotto at room temp for 1.0 hour 
8) Soak in 10mL blotto, .5% Tween-20 and 40000-fold dilution of primary 
antibody 
a. Primary antibody is RGS-His from Qiagen 
9) Wash 3x 30 minutes in 600mL Blotto 
10) Soak in 9mL Maleic Acid Buffer + 1mL 10X blocking reagent 
with 5μL secondary antibody 
a. Secondary antibody___ 
11) Wash 3x 30 minutes with 600mL Maleic Acid buffer with 0.3%     
Tween-20 
12) Add to bag with 1mL BM Purple in dark and soak for 10 minutes 
13) Remove from bag and rinse with nano pure H2O 
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SDS-PAGE Running Buffer 
1) 3g Tris 
2) 14.4 g Glycine 
3) 10mL 10% SDS 
4) Add H2O to 1L 
Western Transfer Buffer 
1) 6.0g Tris 
2) 14.4g Glycine 
3) 200mL Methanol 
4) Add H2O to 1L 
Maleic Acid Buffer 
1) 100mM Maleic Acid 
2) 150mM NaCl 
3) pH to 7.5 
4) Autoclave 15 minutes at 121°C 
1X-PBS Blotto (1 liter) 
1) 100mL 10X phosphate buffer saline 
2) 50 grams nonfat dry milk (5%) 
3) Add H2O to 1L 
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Appendix B:  Pertinent information and Protocols regarding SgAP  
   project using S. lividans expression system 
B-1:  Modified ScAP nucleotide sequence as synthesized by Genscript. 
CCATGGATGCGCATCAAGCGGACCTCCAACCGCAGCAACGCCGCGCGCCGAGTCCGCACCACGGCGGTC
CTGGCGGGACTCGCAGCAGTGGCAGCATTGACCGCCCCCACCCCGGCGGCGGCGGCGGCACCGGACAT
CCCGATCGCGAACGTCAAGGCCCACCTCCGGCAGCTCGAGAGCATCGCGACCGCCAACGGAGGCAACCG
GGCCCACGGCCGTGCGGGTTACCGGGCCTCGCTCGACTACATGAAGGCGAAGCTGGACGCCGCCGGCTT
CACGACTCGTGTGCAGCAGTTTAGCGCGTCGGGCCGTACCGGGTACAACCTGACCGCCGACTGGCCCGG
CGGCGACGCGTCCCAGATCGTGATGGCCGGGAGCCACCTCGACTCGGTGGCTTCCGGCCCCGGTATCAA
CGACAACGGCTCCGGCAGTAGCGCCGTCCTGGAGACGGCGCTGGCGGTCGCCCGATCGGGTTACCAGC
CGACCAAGCACCTCCGGTTCGCCTGGTGGGGCGCGGAGGAGCTGGGCCTGGTCGGCTCCCGGTACTAC
GTCAACTCGCTGGGCAGCGCCGAGCGCGCCAAGATCAGCGGGTACCTGAACTTCGACATGATCGGCTCC
CCGAACCCGGGTTACTTCGTCTACGACGACGACCCGACGATCGAGAAGACCTTCAAGGACTACTTCTCCG
GGATCGGCATCTCCACGGAGATCGAGACCGAGGGCGACGGACGCTCCGACCACGCACCCTTCAAGAAC
GCGGGAGTCCCGGTCGGCGGCCTGTTCAGCGGCGCCGACTACCGCAAGACCTCCGCGCAGGCGGCCAA
GTGGGGCGGCACTGTCGGCCAGCCCTTCGACCGCTGCTACCACTCCAGTTGCGACACCACGGCCAACATC
GATGACACGGCCCTGGACCGTAACAGCGACGCCATCGCATACGCCGTCTGGGAGCTGTCGCAGATCGAG
GGCCGGCATCACCACCACCACCACGGTACC 
 Yellow highlight corresponds to Engineered restriction site for NcoI 
 Green highlight corresponds to signal peptide from Streptomyces  
griseus PB 
 Cyan highlight corresponds to signal peptide from Alpha Amylase 
 
 
 
 
 
 
 
 
 
 
 
Appendix B (Continued) 
B-2:  pUC57 Vector Map (contains Insert) 
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Appendix B (Continued) 
B-3:  pD730 Vector Map 
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Appendix B (Continued) 
Restriction Digest Protocol 
 pD730 Digest 
 For One Sample (ie volumes can be multiplied accordingly, time 
adjusted as needed but not a multiple of the ingredients) 
1) Add to 0.65mL Eppendorf Tube 
a. Nano pure H2O   2.7μL 
b. Multicore Buffer  1.5μL 
c. BSA   0.5μL 
d. SacI   0.3μL 
e. pD730 Vector DNA 10.0μL 
2) Place in 37°C water bath for 4 hours or overnight 
3) Briefly centrifuge to bring condensation down off tube walls and lid 
4) Add 0.3μL NcoI 
5) Return to 37°C water bath for 20 min 
6) Heat inactivate NcoI by placing in 65°C water bath for 15.0 min 
7) Run on Agarose Gel (0.3%) for maximum separation of high weight 
bands 
pUC57 Digest 
1) Add to 0.65mL Eppendorf Tube 
a. Nano pure H2O  2.7μL 
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Appendix B (Continued) 
b. Multicore Buffer  1.5μL 
c. BSA   0.1μL 
d. SacI   0.3μL 
e. NcoI   0.3μL 
f. pUC57 vector DNA 10.0μL 
2) Place in 37°C water bath for 2-4 hours 
3) Heat inactivate NcoI by placing in 65°C water bath for 15.0 min 
4) Run on Agarose Gel (0.7%) for separation of low weight bands 
pD730 requires a partial digest due to the multiple cut for NcoI in its 
sequence (see vector map).  Thus the time exposure to NcoI was 
varied.  pUC57, however, does not have this issue and so the NcoI 
exposure is longer to ensure a complete digest.  The appropriate 
fragment of the vector must be separated from the other bands prior 
to ligation, hence the agarose gels were used.  These bands are then 
cut out of the gel in the next protocol 
Isolating DNA from Agarose Gels  
 Uses MO-BIO’s Ultraclean Gel Spin Kit 
1) Cut band from gel and determine weight, less than or equal to 
200mg 
2) Place in spin filter basket, add three volumes of “Gel Bind” 
a. I.e. if gel weighs 0.2g then add 0.6mL “Gel Bind” 
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Appendix B (Continued) 
3) Incubate 2 minutes at 55°C water bath.  Invert to mix, continue to 
incubate at 1 minute intervals until gel is completely melted. 
4) Centrifuge 10 seconds at 10,000xg 
5) Remove filter, Vortex flow through for 5 seconds 
6) Reload vortexed flow through onto fliter 
7) Centrifuge 10 seconds at 10,000xg 
8) Discard flow through 
9) Add 300μL “Gel Wash” Buffer 
10) Centrifuge 10 seconds at 10,000xg 
11) Discard flow through, centrifuge an additional 30 seconds at 
10,000xg 
12) Discard flow through, add 50μL “Elution Buffer”.   
13) Centrifuge 30 seconds at 10,000xg.  Flow through is desired 
DNA 
14) Concentration can be determined using A260 method 
SAP’d Vector (this time with calf intestinal alkaline phosphatase) 
1) DNA   20μL  
2) Nano pure H2O  65μL 
3) 10x CiAP buffer  10μL 
4) CiAP   5μL 
5) Incubate at 37°C 1.0 hour 
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6) Purify using Amicon Spin column (see Appendix A) 
7) Check A260 to determine concentration 
 
 
 
 
 
 
 
  
